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ABSTRACT 
 
 
IMPLEMENTATION OF PHYSIOLOGIC FLOW CONDITIONS IN  
A BLOOD VESSEL MIMIC BIOREACTOR SYSTEM FOR 
THE EVALUATION OF INTRAVASCULAR DEVICES 
 
 
by 
 
 
Marc C. Dawson 
 
 
 
The prevalence and devastating nature of cardiovascular diseases has led to many 
advancements in the therapies used to treat the millions of patients that suffer as a result 
of these conditions.  As coronary artery disease (CAD) is the most common of these 
cardiovascular conditions, it is a major focus of research among the medical industry.  
Although lifestyle changes and drug therapies can treat early CAD, more advanced cases 
often require more definitive interventions.  In conjunction with angioplasty, stenting of 
an occluded vessel has shown significant success in preventing restenosis.  However, as 
with nearly every therapeutic process in the medical field, several complications have 
arisen in stented patients that pose a need for further improvement of the devices.  As a 
result, the stent industry is constantly striving towards improving the characteristics and 
outcome of their product and with these efforts comes the need for extensive testing and 
research. 
Continuous improvement and innovation in the field of tissue engineering has 
brought about the possibility of creating laboratory grown tissue engineered vascular 
grafts (TEVGs) for the purpose of replacing and/or bypassing damaged or occluded 
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regions of the vasculature.  By employing the techniques used to produce TEVGs, a 
blood vessel mimic (BVM) bioreactor system has been developed with the intent of using 
the resulting construct as a model for testing the cellular response of a human blood 
vessel to an intravascular device such as a stent.  This would allow gathering of more 
significant data in the early stages of device development and may reduce the overall 
costs and time required to refine a design. 
Although the BVM system has previously been used to cultivate viable constructs 
that were subsequently used to observe the response to a deployed stent, the flow 
conditions within the original design are not representative of the physiologic conditions 
in a native vessel.  This aspect of the original system presented a need for development in 
order to be considered by researchers as an accurate in vitro representation of the target 
vessels in which the stents are used.  One of the primary concerns of this environment is 
creating and maintaining physiologic flow conditions that will represent those present in 
native vessels in order to facilitate cells sodded on the construct to grow as they would 
under native conditions.  The two key aspects of flow are pulsatility and wall shear stress. 
 Studies in this thesis were carried out to determine the best and most feasible 
methods for implementing appropriate levels of pulsation and wall shear stress in the 
previously established BVM bioreactor system with the intention of maintaining the 
original system’s simplicity and high throughput potential.  Pulsatile flow was created by 
elevating backpressure in the BVM chamber while using a different pump head and 
pump tubing.  Wall shear stress was adjusted by altering the viscosity of the perfusate and 
flow rate through the system.  Both pulsatile flow and shear stress were established 
without any major changes to the overall configuration of the system. 
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Pulsatile pressures of ~80 mmHg and wall shear stress forces of ~6.4 dyn/cm2 
were established with minimal alteration to the original system.  Pulsatility was created 
by using a 3-roller peristaltic pump head in place of the originally specified 8-roller head 
to create pulses that were then regulated with backpressure created by restricting down 
stream flow.  Increasing the viscosity and corresponding flow rate allowed for instigation 
and control of wall shear stress at the inner wall of the BVM graft.  Although the 
resulting protocols presented here require refinement for ultimately successful 
implementation, they are important underpinnings that will facilitate the eventual 
development of an ideal BVM system that is highly suitable for use as a high-throughput 
intravascular device testing model. 
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Chapter 1: INTRODUCTION 
 
OVERVIEW 
 Along with many other laboratories around the globe, our group is attempting to 
develop an efficient, simple bioreactor system that can be used to grow human blood 
vessels in vitro.  The primary goal of nearly every other group is to produce a Tissue 
Engineered Vascular Graft (TEVG) that can be implanted in human patients who are in 
need of a replacement for vessels that have been rendered dysfunctional by disease or 
trauma [29,33,50,58].  Although our lab aims to meet similar criteria by following the 
same principles of tissue engineering, our Blood Vessel Mimic (BVM) system is in 
development for the purpose of creating an in vitro assay for intravascular devices or 
drugs that will provide in vivo-like results. 
 Creating a viable BVM that has the qualities of a native vessel could provide a 
means to test intravascular devices or drugs that could reduce the cost and danger 
involved in preclinical and clinical trials that rely on animal and human testing.  This 
system could prove to be very desirable to the medical community and device industry as 
it would be a valuable tool that could be implemented early in the extensive development 
process. 
 In its current state, our system has several shortcomings that must be addressed.  
This paper will explore the flow conditions in the system along with the formulation of 
the growth media with the purpose of establishing pulsatile flow and physiologic wall 
shear stress to promote and improve the development of the vessel.  In order to fully 
understand the topic and the research that will be presented here, the physiology and 
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pathology of the cardiovascular (CV) system as well as the current practices, treatment 
methods, and state of TEVG research will be reviewed. 
 
Physiology and Pathology of Vasculature 
The Cardiovascular System 
The cardiovascular system is comprised of three major components: blood 
vessels, which serve as conduits, the heart, which functions as a pump with the primary 
role of transporting nutrients and oxygen-carrying red blood cells throughout the body 
and finally, blood, the carrier.  The two main vessel types, arteries and veins, transport 
oxygen-rich blood to the body’s organs and oxygen-deprived blood back to the lungs.  
Although their primary function is to distribute blood throughout the body, blood vessels 
are not simple tubes of tissue, but rather complex structures designed to regulate blood 
pressure, oxygen and nutrient distribution, as well as to initiate and transmit chemical and 
neuronal signals in an effort to maintain and control cardiovascular function [73].  The 
coronary arteries supply blood to the heart and are of particular importance to this thesis 
as they are the target for devices that we aim to evaluate. 
There are three layers that comprise the vessels of the body (Figure 1.1).  The 
innermost and thinnest layer, known as the tunica intima, lines the interior of the 
cardiovascular system and is continuous throughout the vasculature and heart, existing as 
an antithrombogenic surface that directly contacts whole blood.  The intima, also known 
as the endothelium, is primarily made up of endothelial cells (ECs) backed by a thin 
basement layer of connective tissue.  In some muscular arteries and arterioles, the ECs 
are attached to an internal lamina layer.  The middle layer, the tunica media, is primarily 
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composed of smooth muscle cells (SMCs) supported by a layer of elastic fibers that 
provide mechanical strength.  The SMCs aid in blood pressure regulation via radial 
contraction/relaxation of the vessels; an action that is controlled by a network of nerves 
that stem throughout the medial layer from the autonomic nervous system. 
 
 
Figure 1.1 Basic structure of human blodd vessels [4]. (Permission to reprint figure 
granted by Encyclopedia Britanica. See Appendix D) 
The outermost and thickest layer, known as the tunica adventia, encapsulates the vessel to 
provide overall strength and appropriate compliance with varying blood pressures.  The 
adventia is primarily composed of collagen and elastic fibers.  In thicker vessels, a 
microvascular network known as the vaso-vasorum passes through the adventitia to 
supply the medial layer with blood.  However, in thinner vessels, this process occurs via 
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diffusion.  The nerves that control the SMCs of the medial layer also pass through the 
adventitia. 
 
Clinical Pathologies 
 Complications and diseases of the cardiovascular system, specifically of the blood 
vessels, are a leading cause of death and disability in the United States and the rest of the 
world, resulting in nearly 870,000 deaths in 2005 in the U.S. alone [5].  Coronary artery 
disease (CAD) is the most common of these ailments leading to more than half of these 
deaths [5].  Although preventative measures such as lifestyle modification or drug 
intervention can reduce the chances of developing these conditions, their presence often 
goes undetected for too long and damage to the vessels is irreparable. 
An underlying condition that gives rise to many CV diseases and disabilities is 
arteriosclerosis.  This condition is a result of damage, stiffening and subsequent 
inflammation of the endothelial layer of blood vessels or heart and often results in a 
restriction of blood flow to tissues and/or organs.  The major type of arteriosclerosis is 
atherosclerosis, in which atheromas (plaques of fatty deposits) form on the inner walls of 
arteries (Figure 1.2) [6,49,77]. 
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Figure 1.2 Plaque deposition in atherosclerotic artery [4].  (Permission to reprint 
Figure granted by Encyclopedia Brittannica.  See Appendix D) 
Atherosclerosis is progressive and typically begins in all people, to some degree, at birth 
[6,49,77].  The result is a hardening and/or narrowing of the arteries due to thickened 
arterial walls or plaque formation.  Plaque lesions form on the endothelial layer usually as 
a result of lifestyle (high fat diet, low activity level, smoking, etc.) or genetic 
predisposition and if not addressed, may proceed to grow inward, reducing the size of the 
vessel lumen possibly resulting in vessel occlusion [6].  There are two common types of 
plaques: hard stable and soft unstable.  The hard and stable type often cause luminal 
reduction, where as the soft and unstable type are more likely to break free from the 
vessel wall, causing a flow-impeding clot downstream that may result in organ damage or 
death.  Further complications that can result from impeded blood flow or released clots 
are myocardial infarction (MI), ischemic cardiomyopathy, ischemic and hemorrhagic 
stroke and peripheral artery disease [49,77].  Vessel occlusion can be treated with drugs 
or interventions such as angioplasty or stenting as discussed below. 
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CAD Treatment Options 
 When treatment beyond drug therapy and lifestyle adjustments is required for 
patients with CAD, there are several options including coronary revascularization (or 
coronary bypass grafting - CABG), coronary angioplasty, and coronary stenting.  CABG 
involves the use of a portion of a healthy vessel from the patient’s chest or leg to redirect 
blood around the lesion site(s) restoring proper flow [7].  This is a highly invasive 
procedure that requires opening the chest cavity and a recovery period of 4-8 weeks [78]. 
 Angioplasty, a less invasive option, involves the insertion of a catheter equipped 
with an inflatable balloon into the occluded vessel (Figure 1.3).  The balloon portion of 
the catheter is positioned at the site of occlusion where it is then inflated in hopes that the 
occlusion will be forced open, restoring proper blood flow.  According to the American 
Heart Association’s 2008 Update to Heart Disease and Stroke Statistics Report, in 2005 
there were over 1,250,000 angioplasties performed in the United States [8].  It is 
estimated that nearly 95% of all angioplasties (with or without stenting) performed in the 
United States annually have initially successful outcomes, where success is defined as 
prevention of death or the need for an emergency CABG [65].  Stenting, which involves 
the deployment of a tubular mesh structure in an occluded vessel, has improved this 
success rate by reducing the need for emergency CABG from ~6% to less than 1% [87]. 
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Figure 1.3 Angioplasty with deployment of intravascular stent [3].  (Permission to 
reprint Figure granted by Encyclopedia Brittannica.  See Appendix D) 
The FDA originally approved coronary stents for use when the results of 
angioplasty were suboptimal [87].  Their use has since increased with approximately 91% 
of angioplasties performed in 2007 including the placement of a coronary stent to hold 
the vessel open, thus reducing the chance of restenosis and the need for a repeated 
procedure [8]. 
 Commercially available stents are commonly of two types: bare metal and drug 
eluting.  Stents consist of a structural cage made of specific alloys such as 316L stainless 
steel and cobalt chromium that are designed to be as biocompatible as possible so that 
when implanted the metal from which they are made is accepted by the body [44].  As 
with most implantable devices, there is a necessary balance between preventing rejection 
and promoting some degree of tissue integration while avoiding tissue over-growth.  In 
the case of coronary stenting, this integration occurs in two processes: neointimal 
generation and endothelial regeneration [27].  Neointimal generation, which is typically 
considered a problematic response, involves an initial inflammatory response followed by 
an influx of lymphocytes and then SMCs around the struts of the stent in as little as 72 
hours [27,66].  Endothelial regeneration, which is typically considered a desirable 
 8 
response, includes the influx of Factor VIII positive endothelial cells with complete 
coverage occurring in about 96 days in humans who have received a Bare Metal Stent 
(BMS) [27].  Extensive cell proliferation or neointimal hyperplasia in response to the 
metal stent itself can result in restenosis of the vessel and a negation of the effects of the 
procedure [52].  This has been a major complication in vascular stenting occurring in up 
to 80% of patients at 6 months post procedure and has lead to the development of drug 
eluting stents (DESs) [52,71]. 
 Drug eluting stents are structurally similar to bare metal stents but are often 
coated with a polymer that is infused with an anti-inflammatory drug such as paclitaxel, 
dexamethasone or the limus drugs [52,72].  Cytostatic compounds such as these were 
thought to be the solution to neointimal hyperplasia by preventing cell replication at the 
implantation/injury site.  However, several new issues have arisen that have inhibited the 
success of these devices [52,71,72].  Because these compounds reduce cell proliferation, 
they consequently inhibit healing at the site as well as proper cellular integration of the 
stent itself and can lead to coronary thrombosis [52].  Additional issues regarding the 
success of DESs include achieving proper drug concentration and potency, 
biocompatibility of the polymer coating, and maintaining long term efficacy of the drug 
[52,71,72].  Controlling this has been the target of many studies and due to the complex 
nature of cellular growth, has yet to be perfected [71,72]. 
 As discussed above, a stent has not yet been developed that is entirely effective at 
consistently preventing restenosis while achieving proper tissue integration.  For this 
purpose, an in vitro tissue engineered BVM system could be an ideal testing environment 
as it would allow the study of the human tissue response to different bare metal and DES 
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configurations that could reduce the cost and danger of animal and human studies.  Due 
to the importance of preclinical testing for newly emerging stents and other intravascular 
devices, the following section will briefly review currently employed preclinical 
procedures. 
 
Preclinical Testing of Intravascular Devices 
 The invasiveness and life supporting nature of intravascular devices requires that 
they undergo extensive testing prior to approval for use in people [35].  Although the 
final step in this process is ensuring safety and efficacy through clinical trials, a process 
that can take years and cost millions of dollars, the preclinical trials are also extensive, 
time consuming, and costly.  Preclinical trials include bench, in vitro and animal testing, 
and typically aim to show that the device’s design is appropriate for a given application 
and will not be toxic or damaging to the person receiving it.  These preclinical studies can 
take 2-3 years and cost $10-20 million dollars [35,53].  Once a device passes this step, it 
is subject to approval for use in clinical trials in humans.  This approval process in and of 
itself can take three to six months [35].  Following evaluation of the clinical trials, 
devices can potentially be approved for market. 
Many preclinical testing methods have been developed that provide an estimation 
of the human body’s response to a device.  Bench and in vitro testing include biochemical 
assays that assess biocompatibility, cytotoxicity and the potential for thrombogenicity, as 
well as mechanical testing that determines if the structural characteristics of the device 
are appropriate for its intended use [53].  For example, DESs have been tested using in 
vitro cell cultures to determine the effect of dexamethasone on SMCs and in porcine 
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animal models to observe the development of neointimal hyperplasia in response to 
implantation of a sirolimus-eluting stent [38,63,88].  Although these methods are good 
approximations, there is still a need for more physiologic and more cost effective 
methods, respectively. 
 Animal testing involves implanting the device in an appropriate lab animal and 
evaluating the tissue response to the device [38,88].  When testing a coronary stent for 
example, the stent is implanted in the iliac or coronary artery of an animal (often a rabbit 
or a pig) using similar methods as would be used on a human patient.  Depending on the 
study, the artery containing the stent is excised at specified time points and analyzed for 
responses including platelet and fibrin deposition, infiltration by blood and vascular cells 
and the formation of extracellular matrix (ECM) and collagen fibrils [81].  While animal 
testing is one of the gold standards in device development and allows for the examination 
of a device in vivo, in some cases, such as endovascular stenting, it has proven to be a 
poor example of what will occur when the device is introduced in a human subject [81].  
In the case of stents, it has been shown that an animal model can predict responses to 
stenting but the demonstrated time period is typically much shorter than in humans [81].  
This may be due to the fact that stents implanted in test animals are placed in clean, 
lesion free vessels rather than damaged, sclerotic ones [81].  Another possibility is that 
the healing time and thus the tissue response rate is proportional to the lifespan of the 
animal [81].  An animal with a shorter lifespan may have a faster healing rate leading to 
inaccurate results when predicting time and longevity of a device in humans. 
 The next step following successful animal studies is to determine the acceptance 
of and response to the device in human subjects through clinical trials [27,59].  Although 
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preclinical trials can help in determining whether a device will be accepted by or cause 
major complications in the body, the device may fail clinical trials making the extensive 
time and money expended to bring a device to this point in development lost.  This is 
often the case with many devices [35] and it would be beneficial if there were a way of 
testing the device in appropriate human tissues before getting to the point of clinical 
trials.  Tissue engineering could be employed to create a sample tissue that could be used 
for this purpose. 
 
Tissue Engineered Blood Vessels as preclinical device testing models 
 For several years, great efforts have been made to produce tissue engineered 
vascular grafts with the intent of implanting them into patients needing bypasses or 
vascular repair who cannot provide an autologous graft [29,33,50,58,64,85].  These 
efforts are of considerable merit and could be of great benefit to a vast patient base [5].  
Using similarly produced grafts as living vessel models in preclinical testing of novel 
intravascular devices could provide value by decreasing the time and cost of development 
and approval of the many valuable devices that can benefit thousands of people. 
Until an ideal device is developed and made readily available, there will always 
be efforts towards continuous improvement of current devices.  Each measure of 
improvement, regardless of the degree of change, will be subjected to testing and 
approval and thus great expenditures and scrutiny by regulatory bodies.  That said, an 
effective, accurate in vitro model could reduce initial testing costs and improve final 
success rates for the industry while providing data to regulatory agencies to back the 
safety and efficacy of these devices.  
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Financial Concerns 
 Assuming that the BVM system can be developed to produce tissue that is very 
similar to native vessels, not only would it be desirable to device companies for its early 
indicator capabilities, but it could also give valuable data at a fraction of the cost of 
animal testing.  For the purpose of intravascular devices, rabbits are the preferred animal 
used in initial animal testing for the size and similarity of their iliac arteries as compared 
to human coronary arteries.  For example, there are no functional stents that are small 
enough to implant in mice.  Although it is difficult to attain exact figures regarding the 
total cost of testing coronary stents in animals, as it varies greatly with device and 
research group, the costs of the actual lab animals were available from Charles River 
Laboratories [15].  Disregarding size and sex, the least expensive rabbit available from 
Charles River is $84.55.  When size and sex are of importance, costs can reach as much 
as $183.55 per rabbit. 
For chronic studies, a major US vascular device company uses United States 
Department of Agriculture purpose bred dogs that cost ~$3000 per animal [16].  These 
costs are for the animal only and do not include housing, surgery and maintenance costs.  
Equipping a facility for survival surgeries and maintenance of up to 200 test animals can 
easily reach $1.3 million [16].  If a device company performs the testing in-house, the 
cost of consumables used in a survival surgery alone are approximately $1000 per animal 
and maintaining that animal in an IACUC approved facility before and after surgery costs 
around $20 per day, per animal [16].  Additionally, staffing the facility with a 
veterinarian and two technicians can cost an estimated $240,000 per year.  Excluding 
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surgery costs, when taking all expenditures into account, the annual cost for maintaining 
an animal testing facility with 200 animals on hand approaches $2 million per year [16]. 
In comparison, the current generation of BVM bioreactor system is approximately 
$15.25 for the growth chamber, tubing and media reservoir.  This does not include the 
cost of incubators, pumps, media solutions, scaffold materials and cell cultures, however 
several of these costs are incurred only upon initial setup of the testing facility as they are 
reusable equipment.  The initial cost required to equip a laboratory with the necessary 
hardware to produce up to thirty-two steady flow or sixteen pulsatile flow systems, is 
approximately $47,000.  Once the testing facility is established, excluding labor costs, the 
only cost is consumables, which amounts to approximately $100 for each graft setup. 
 The financial comparison discussed above is not meant to show that the millions 
of dollars spent on animal testing can be saved by replacing animal testing with our 
device, but rather that our device can help improve the triage process when deciding 
when and what devices should proceed to animal testing.  When used in this way, there 
would be a great potential savings in testing costs as our system could be used to 
eliminate faulty designs early in the development process before placing it in animals. 
 Along with the financial concerns, use of our system in the development process 
could affect IACUC decisions and ethical dilemmas surrounding animal testing.  Not 
only would unnecessary animal testing be reduced, but also animal studies could actually 
be improved as the decision on the number of animals to use could be adjusted based on 
data gathered from our system. 
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BVM as a Testing Environment  
A novel bioreactor system has been developed by our laboratory that has potential 
for use in intravascular device testing by creating a Blood Vessel Mimic (BVM) that can 
be grown in vitro for the purpose of deploying a stent and studying the human cellular 
response to the device [12].  However, in its current state, the environment in which the 
graft is grown is not truly representative of a physiologic vessel environment. 
The luminal flow through the vessel lacks pressure fluctuations that would 
represent cardiac output (See Figure 1.4. Note difference in scale of Y-axes) and the 
viscosity of the media is well below that which is required for proper shear stress and cell 
alignment.  The shear stress in native arteries is >15 dyne/cm2 and the minimum required 
for proper EC alignment is 6-10 dyne/cm2 [25,28,42,46].  The shear stress produced by 
the media in our original steady flow system is ~0.359 dyne/cm2 when using a 4mm graft 
at 15 ml/min. 
 
Figure 1.4 (A) Pressure waveforms of steady flow BVM and (B) native arteries [B 
from 60].  (Permission to reprint figure granted by British journal of clinical 
pharmacology.  See Appendix D) 
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 A primary principle in tissue engineering involves the creation of an environment 
that best simulates the physiologic conditions in which the target tissue grows with the 
idea that this will produce a tissue that is more like the native tissue [11,54].  The 
engineered tissue must be of the appropriate cell type and structure and in the case of 
TEVGs, one of the main issues is orientation and development of the medial and intimal 
layers [50].  Two key factors that affect the cell orientation in vascular grafts, and 
therefore must be addressed in the in vitro BVM system as well, are flow conditions and 
shear stress experienced by the cells in the endothelial layer [10,29,33,50,58,64,85].  
Thus, the flow in a TEVG or the BVM bioreactor chamber would ideally mimic or 
simulate specific aspects of the conditions found in native vessels; the varied pulsation 
characteristic of cardiac output as well as the shear stress created by the viscosity of 
blood. 
 
Importance of Pulsatile Flow 
 Pressure fluctuations within native blood vessels are a natural occurrence due to 
the cyclic nature of the heart [61].  This cyclical change in hydrostatic pressure creates 
varying hoop stresses on the walls of the vessels resulting in varied strain in the tissue of 
the vessels [69].  As the pressure increases in the vessel the luminal diameter increases 
slightly.  This change in the diameter results in axial strain that, according to Poisson’s 
effect, results in transverse strain in the material [40].  These strains are thought to induce 
a cellular response that affects cell differentiation during vessel development, mechanical 
properties, and cell orientation [69,84,88].  Many methods have been developed to 
achieve proper mechanical stimulation and they all have presented similar results with the 
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overall finding that in order to produce a native-like vascular graft in vitro, cultivation 
should be carried out in the presence of pulsatile flow. [10,68,58,69] 
 As described by Seliktar et al [68], when rat Smooth Muscle Cells (SMCs) were 
cultured and grown in collagen-based gel scaffolds under pulsatile conditions, there was 
an observed improvement in mechanical strength, SMC orientation, and collagen fibril 
organization.  After 4 and 8 days of growth under pulsatile flow at 1Hz to obtain 5 and 
10% strain, the constructs grown under 10% strain had better collagen lattice 
reorganization than those grown under 5% strain.  Subsequently, the mechanically 
conditioned constructs exhibited better mechanical properties and contractile function 
than the unconditioned controls grown under steady flow.  Histologic examination also 
revealed that the constructs grown under pulsatile conditions showed improved 
circumferential SMC orientation and collagen fibril orientation when compared to the 
unconditioned control constructs [68].  Therefore, this study supports the notion that 
implementing physiologic conditions in tissue-engineered blood vessels is key to 
producing a native-like construct. 
 Similar results were found in a 1999 study lead by Niklason et al [58].  This group 
focused on the development of smaller diameter (<6mm) autologous arteries that could 
be used in bypass grafting.  Bovine aortic smooth muscle cells were seeded onto a 
Polyglycolic Acid (PGA) scaffold where they were grown under pulsatile flow for eight 
weeks.  The gross appearance of the vessels at this time point was stated to be “identical 
to that of native arteries” and further histology showed migration of the SMCs in a 
manner that would provide an ideal surface on which ECs could be seeded.  In contrast, 
the control constructs grown under steady flow exhibited no such migration and 
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organization.  Histologic and mechanical analysis of the constructs revealed little 
difference in the SMC density, but considerable improvement in suture retention strength 
and collagen content was seen in the pulsed constructs.  With the knowledge that 
pulsation produces better phenotypic examples of vascular constructs, the group then 
tested the constructs in animal models.  Both the pulsed and non-pulsed grafts were 
implanted in the right saphenous artery of swine.  The non-pulsed grafts developed 
thrombosis after 3 weeks while the pulsed grafts remained patent after 4 weeks post 
implant.  Although they cited the need for longevity studies of their grafts, results showed 
that pulsatile conditions are important in the development of a successful TEVG. 
 Many studies confirm the need for pulsatile flow to produce a vascular graft with 
native-like properties suitable for implantation.  However, the majority of these studies 
have been performed using extensive culture times with complex bioreactor systems 
[58,68].  One of the objectives of our system is to develop a high throughput model with 
minimal complexity.  Therefore, we will look to develop a method of achieving similar 
results with less equipment and components. 
 
Importance of Wall Shear Stress 
 Although wall stretch via pulsatile flow is important to vessel development, shear 
stress has also been shown to be of particular importance in the phenotypic development 
and proper orientation of the vascular endothelial cell layer [12,25,26,45,86]. The flow of 
a fluid through a tube, in this case blood through blood vessels, creates tangential or shear 
forces on the inner walls of the tube [1,42].  These wall shear stresses are directly 
proportional to the velocity at which the fluid flows and the viscosity of the fluid [1,82].  
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The flow of blood through a vessel creates shear stresses on the endothelial layer that 
vary constantly depending on location or physiologic needs that can alter heart rate 
and/or blood viscosity [26,37].  There is, however, a constant baseline shear when the 
heart rate and blood viscosity are at their lowest.  Consequently, it has been determined 
that shear forces have considerable influence on the development and progression of 
conditions involving the EC layer such as atherosclerosis and restenosis [46,74,83].  
Similarly, it has been shown that shear stress affects the alignment of SMCs as well [42].  
With this in mind, controlling the shear stress seen at the graft wall of our BVM system is 
very desirable, as it would allow the study of intravascular devices under varying 
conditions.   
 Due to its significance in cellular response, there have been many studies on the 
effect of shear stress on EC and SMC orientation and development [25,26,42,45,86].  It 
has been shown that shear stress affects the phenotypic behavior of the individual 
vascular cells, and as a result, alters the macroscopic characteristics of blood vessels and 
their responses to diseases [37,46,74,83,89]. 
 As vessel physiology dictates, endothelial cells experience direct contact with 
blood flow and thus are directly and immediately affected by shear forces caused by 
blood flow.  Malek et al showed that shear stress induces macroscopic organization of 
bovine aortic endothelial cells (BAECs) as well as changes in the activity of several 
intracellular signaling cascades that affect the cellular cytoskeleton [45].  The alignment 
of the cells is thought to be important in controlling the shear forces experienced by the 
cells and the changes in the structure of the cells themselves is believed to be important 
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for their ability to withstand increased shear forces that may be imposed during increased 
physical activity [45]. 
Shear stress has also been found to induce changes in endothelial progenitor cells 
(EPCs), indicating that its presence is not only important to the maintenance of existing 
vessels, but to angiogenesis as well [86].  By exposing EPCs to low stress levels (0.1 -2.5 
dyne/cm2) for 24 hours, Yamamoto et al observed differentiation, proliferation and 
subsequent morphologic changes consistent with the development of mature ECs [45].  
This occurrence was verified by time-dependent increases in levels of genotypic 
expression factors and adhesion molecules.  Consistent with its role in promoting 
proliferation and differentiation, shear stress was also found to promote tube formation 
by EPCs [45].  Capillary-like tubes not only appeared more rapidly, but also the length of 
the tubes was dramatically longer in cultures grown under increased shear [45].  
Although this study regarding the behavior of EPCs is not directly relevant to this thesis, 
it illustrates that shear stress is important to vascular cells from their inception and lays 
groundwork for potential future work using our system. 
 Shear stress, independent of luminal pressure, has been shown to affect the 
behavior of blood vessels by an observed dilation of arterioles in response to increased 
flow velocity and/or perfusate viscosity, both of which result in increased wall shear 
stress [37].  Koller et al isolated arterioles from rat cremaster muscle and cultured them 
using a perfusion bioreactor system in the absence of dilation signaling agents with 
constant pressure of 60 mmHg [37].  Experimental runs were done using vessels with and 
without the endothelial layer [37].  Stepwise increases in shear stress resulted in stepwise 
increases in the diameter of vessels with the endothelial layer intact, while vessels that 
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had the EC layer removed showed almost no dilation [37].  In addition, higher shear 
levels elicited a greater degree of vasodilation when compared to lower shear [37].  
Along with the observed change in cell alignment, this result may be evidence of 
autoregulation of the wall shear stress by ECs that may serve as an autoprotective 
mechanism, which further regulates and maintains the state of blood vessels throughout 
the body. 
Along with its effects on the development and maintenance of healthy vessels, 
shear stress has been implicated in the development and progression of vascular disease 
[46,74].  As a follow up study to their work on the role of shear stress in the changes of 
endothelial shape cytoskeletal structure, Malek et al looked into the effect that shear 
stress has on atherosclerosis [46].  Although this disease is related to risk factors 
including genetic predispositions and lifestyle trends, this study claims that 
atherosclerotic development is primarily a geometric disease.  This claim is based on the 
fact that physiologic shear stress (~15 dyne/cm2) improves phenotypic EC expression and 
atheroprotective qualities while low shear stress (<4 dyne/cm2) induces atherogenic cell 
type [46].  By analyzing the shear stress characteristics of different regions of native 
blood vessels, a correlation has been shown between areas of decreased shear stress and 
an increased incidence of atherosclerotic plaques [46].  Areas of this type include natural 
vessel bifurcations as well as surgically altered vessels where shear stress is changed by 
the characteristics of flow [46].  As seen in Figure 1.5, reduced shear stress is consistent 
with the formation of atherosclerotic plaques [46].  Stone et al confirmed the effects of 
decreased wall shear stress in the thickening of arterial walls and atherosclerotic plaques 
with little to no change in the luminal diameter and observed an increase in intima-medial 
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thickness in stented arteries [74].  Due to the fact that a stent decreases the effective 
diameter of a vessel, it was found that the region in and around the stented portion of the 
vessel experienced increased shear stresses and as a result, thickening of the vessel wall 
due to neointimal hyperplasia that resulted in an increase in a decrease in the luminal 
diameter [74].  This may contribute to restenosis seen in patients who have received 
vascular stents. 
 
Figure 1.5 Flow analysis of arterial bifurcation. (A) Schematic illustration of the 
focal nature of atherosclerosis and its tendency to involve the outer walls of vascular 
bifurcations such as the carotid, coronary, renal, and iliac artery flow dividers. (B) 
Velocity map of the carotid bifurcation at end-systole using computational fluid 
dynamic modeling illustrates the lower velocities seen at the outer lateral edges 
(blue). The computed wall shear stress (bottom) shows the focal low shear 
magnitude at the outer walls that correspond exactly to the atherosclerosis-prone 
areas of the carotid bifurcation (compare with B) and is in contrast with the less 
susceptible inner regions of the bifurcation where flow velocity and, consequently, 
hemodynamic shear stress at the vessel wall is higher (yellow and green). (Figure 
and caption from [46].)  (Permission to reprint figure granted by JAMA.  See 
Appendix D) 
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Although the role of shear stress in the development of plaques will not be 
directly explored in this thesis, an understanding of it is relevant to this work as it is 
further evidence that proper shear stress is of great importance to the proper development 
of blood vessels and therefore, an important aspect to include in our system.  In addition, 
this information could be used in future work with our system to assess the validity of 
various stent designs and their effect on plaque development, tendency for restenosis 
and/or the overall flow characteristics of the vessel. 
 
GOALS OF THIS THESIS 
 In continuance of research and development of a Blood Vessel Mimic bioreactor 
system [12], this thesis aimed to improve the current system by implementing 
physiologic flow conditions that more accurately represent a native vessel for use in 
intravascular device testing.  This work was carried out in two phases.  The first phase 
was the development and characterization of a pulsatile flow environment similar to that 
found in the native human circulatory system.  The second phase was the formulation and 
implementation of a growth media to generate an increased shear force at the endothelial 
cell surface.  Upon completion of the development of these features, each was 
implemented into the BVM system to assess whether or not the engineered vessel would 
withstand the adulterated conditions. 
 
HYPOTHESES 
 The initial focus of this thesis was to establish pulsatile flow.  The current system 
relies on a peristaltic pump to create steady flow through the graft.  It is hypothesized that 
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a similar peristaltic method can be used to establish pulsatile flow by incorporating a 
different pump head and adding backpressure to establish appropriate pressure 
fluctuations.  Although simulating the pressure fluctuations exactly as found in vivo 
would be ideal, the primary objective of this thesis will be to create pressure waveforms 
similar in shape to physiologic blood pressure while focusing on the pressure differential 
rather than the ultimate pressure levels.  Pulsatile flow in the system will be established 
and controlled by altering the system configuration while monitoring pressure levels 
using a pressure transducer to achieve desired waveforms.  Initial testing will involve 
altering the system settings under real-time pressure monitoring to establish and specify 
settings that can later be used to consistently establish system pressure during graft 
cultivation. 
 The second phase of this thesis was to increase and control the shear forces on the 
endothelial layer.  The current system uses a growth media with unspecified viscosity or 
shear rate.  It is hypothesized that the addition of a media supplement can be used to 
augment and control viscosity and thus the wall shear stress experienced by the cells 
grown in the construct.  The viscosity of the augmented media will be determined and 
specified for varying levels of the thickening agent using a Vilastic-3 viscometer   This 
study will test two different additives that will be used to control the viscosity of the 
growth media and thus the shear force experienced by the cells.  The two agents that will 
be tested are Methyl Cellulose and Dextran, both of which will be used in varied 
concentrations to create varied viscosities.  It is important that the supplement not 
negatively impact cell growth and both of these reagents have been used in cell culture 
and are thought to be capable of establishing the desired viscosity while not impeding the 
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growth characteristics of the cells involved [24,25], an aspect that will be tested prior to 
its introduction to the system.  The supplement will be used in a concentration that 
establishes the desired shear stress while maintaining some degree of cell adhesion on the 
scaffold.  Again, this is a minor alteration of the original system that is thought to be a 
practical solution to the need for the presence of controllable shear force where there is 
currently none. 
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Chapter 2: DEVELOPMENT OF PULSATILE FLOW SYSTEM 
 
INTRODUCTION 
As the cardiac cycle and the nature of the heart as a pump dictates, the flow in the 
cardiovascular system exhibits pulsatile flow [36,39,60].  Noninvasive techniques have 
allowed the collection of data used to generate pressure waveforms demonstrating this 
pulsatile quality [36,60].  Pulsatile hemodynamic forces result in transmural strain that 
the vessel must resist with circumferential hoop stress that can be estimated with 
Laplace’s Law; σ = P•R/t (P – luminal pressure, R – vessel radius, t – vessel wall 
thickness [39]. 
In native blood vessels, this cyclic fluctuation in hoop stress has physiologic 
effects that induce arterial remodeling and alteration of vessel properties [41] by eliciting 
responses from smooth muscle cells (SMCs) and endothelial cells (ECs) [28,41,62,69].  
Mechanical stretching of the vessel wall has been shown to affect the phenotype, 
orientation, extracellular matrix (ECM) deposition and growth factor release in SMC 
cultures [28].  These changes in the SMC layer are significant as they improve the 
mechanical integrity of the vessel and the presence of growth factors may improve 
phenotypic expression and orientation of not only the SMCs, but the EC layer as well 
[28].   
The effects of pulsation have also been shown to directly affect the phenotypic 
expression of ECs [21,23,62].  This has been revealed through the detection of the release 
of an Endothelium Derived Hyperpolarizing Factor (EDHF) in porcine coronary arteries 
[62].  EDHF is a contributor to vessel size and is a component in the regulation of vessel 
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constriction and relaxation [79].  Not only has pulsatile stretching been shown to simply 
affect the release of EDHF but it has also been found that it actually enhances its 
expression and activity in coronary arteries [21].  Along with enhancing EDHF 
expression, it has been demonstrated that pulsation affects the basic EC phenotype as 
well with an observed population of “normal” cells in regions of the vessel where strain 
resulting from luminal pressure was the greatest [23]. 
 Due to the demonstrated importance of pulsation in creating a phenotypically 
accurate vascular graft, the development of a TEVG for implantation or device testing 
must include a method for simulating native pulsatile flow produced by the heart.  Many 
approaches have been taken in attempting to best achieve this goal by groups aiming to 
produce a viable, implantable TEVG.  There are several examples of nearly ideal 
waveforms, however the systems developed by these groups are rather complex and 
include many components that must be separately tuned and maintained [28,29,60,85]. 
To simulate physiologic pulsatile flow, M.S. Hahn et al employed modified 
Cellmax pumps from Spectrum Labs to control pressure and thus pulsation within their 
system.  A peristaltic pump drove primary flow of the perfusion fluid, which then passed 
through a compliance chamber to damp pulsation created by the peristaltic pump.  Fluid 
then passed through the Cellmax pumps, which controlled pulsation by compressing or 
massaging the tubing.  Check valves were placed before and after each Cellmax pump to 
prevent back flow.  A multi-construct chamber was placed downstream of the Cellmax 
pumps with an inline pressure transducer to monitor fluid pressure at the construct 
chamber while the system was running [28].  A diagram of this system and resulting 
pressure waveforms can be seen in Figure 2.1.  One key aspect of this system is that 
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pulsation is controlled externally to the flow path with the intent of reducing the 
opportunity for contamination by avoiding media contact with pump components. 
 
Figure 2.1 Pulsatile flow bioreactor by Hahn et al (A) Schematic of system design, 
which includes (1) one or more pulsatile pumps, (2) custom graft chamber, (3) 
media reservoir, (4) a peristaltic pump, (5) compliance chamber, (6) check valves. 
(B) Close up of the graft chamber. (C) Representative pressure waveforms 
generated using the bioreactor (D) image of the actual bioreactor system. [28]  
(Permission to reprint figure granted by Springerlink publications.  See Appendix 
D) 
S.P. Hoerstrup et al used a pulse-duplicating pump to create pulsation in their 
TEVG bioreactor system.  Media was drawn into the pulse duplicator from a media 
reservoir and sent to four vessel constructs housed in a bioreactor chamber and returned 
to the media reservoir.  Pulsation was created by cyclic expansion and relaxation of an 
elastic membrane within the pulse duplicator.  The expansion/relaxation was controlled 
by an external dual-phase air pump, which acted by inflating and deflating the membrane.  
See Figure 2.2 for the layout of this system [29].   
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Figure 2.2 Diagram of bioreactor system by Hoerstrup et al [29].  (Permission to 
reprint figure granted by Elsevier publications.  See Appendix D) 
Although this system has fewer components than the Hahn system, the growth media 
passes through and directly contacts the internal workings of the pulse-duplicator, which 
can result in contamination of the system. 
A more simplified approach was taken by Williams and Wick to develop a 
pulsatile bioreactor system.  In this design, cell seeding and cultivation occurred using 
two different pump configurations in the same basic system.  During cell seeding and for 
24 hours thereafter a reciprocating dual syringe pump drove luminal flow.  Media was 
concurrently pumped through the growth chamber external to the graft by a peristaltic 
pump to promote nutrient transport from the outer surface of the construct.  Following the 
24-hour seeding period, the dual syringe pump was replaced with a peristaltic pump to 
produce pulsatile luminal flow.  This system requires more than one pump configuration, 
however pulsation is derived solely from a single peristaltic pump without the need for 
compliance chambers or flow controllers.  The means for achieving pulsatility is this 
system are similar to our system, however there are two separate flow paths and flow 
meters in place that make it more complex than ours. 
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 Due to the demonstrated need for pulsation in an in vitro TEVG or BVM 
bioreactor system, the goal of the work presented in this thesis was to make changes to 
the current BVM system, described in Chapter 1, that would allow for an accurate 
simulation of the pressure fluctuations experienced by native vessels.  In describing this 
work, the development and implementation of the alterations to the system will be 
discussed along with the results of preliminary BVM construct cultivation under pulsatile 
flow. 
 
MATERIALS AND METHODS 
 The development of pulsatile flow in our system was approached with the 
objective of making moderate modifications meant to minimize changes to the overall 
usability and simplicity of the current setup.  Thus, prior experience with peristaltic pump 
systems directed the thought that the desired pressure fluctuations could be attained by 
selecting a different pump head, specifying a larger diameter tubing for use at the roller 
interface, and slightly modifying bioreactor system configurations. 
 
Pump Head and Tubing Selection 
 For the desired pulse and flow rates, a 3 and 4-roller pump head (Cole Parmer P/N 
HV- 07519-05 and HV-07519-06) and pump tubing from Masterflex were considered.  
Data regarding the flow rates expected from different pump head and tubing 
combinations at varied RPMs was obtained from the manufacturer.  In order to make the 
best initial choice of pump head configuration and tubing size for our application, these 
data were used to extrapolate estimations of flow rates at pump speeds that would be used 
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in this system.  The actual flow rates were later tested to determine true flow rates at 
specified pump settings. 
There were several material types available in the L/S 16 (Cole Parmer Model 
number) size and after studying their qualities; the Platinum Cured Silicone material 
(Cole Parmer P/N 96440-16) was selected for its biocompatibility and permeability to 
gases.  The gas permeability of the tubing is important as it allows for oxygen and carbon 
dioxide exchange in the growth media without the need for a sterile vent filter on the 
media reservoir. 
 
Actual Flow Rate vs. Pump Speed 
The original design of our BVM bioreactor system calls for flow rates between 10 
and 15ml/min [12].  Since our lab uses different pump drives and pump heads than were 
used previously, it was necessary to determine what RPM settings on our pumps would 
produce the desired flow rates.  This was determined by simply measuring the displaced 
volume after one minute at various RPMs.  This was performed for both the steady flow 
setup with the 8-roller pump head and the pulsatile setup with the 3-roller pump head. 
 
Pressure Monitoring System 
 Although it was hypothesized that pulsatile flow could be established using a new 
tubing and pump head setup, the degree to which the pressure fluctuation could be 
introduced and controlled was unknown.  To quantify this characteristic of the system, an 
AD Instruments Powerlab 4/25 data acquisition system was used.  System pressure was 
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detected using a blood pressure specific, reusable pressure transducer (ADI P/N 
MLT0699) and recorded using the LabChart software. 
 Prior to taking pressure readings for the BVM setups, the ADI recording system 
was calibrated for a 0-200mmHg range using a mercury-filled manometer to establish a 
two-point calibration that allowed the software to translate the incoming signal into 
accurate pressure readings.  Along with its particularly ideal applicability to this study in 
its ability to accurately measure pressure changes in the physiologic range with great 
sensitivity, the ADI system’s software also has the advantage of being able to further 
extrapolate data using preset or user defined algorithms.  Therefore, not only were 
instantaneous pressure readings and changes recorded, but also corresponding pulse and 
flow rates could be calculated and plotted at different pump speeds.  Table 2.1 outlines 
the overall approach and tests that were performed during the characterization work.  
Table 2.1 Outline of tests performed using AD Instruments Data Acquisition 
System. 
 
Characterization of Original Steady Flow BVM System 
 With the pressure recording system calibrated, the flow characteristics of the 
original steady flow system were examined.  A system was set up exactly as originally 
designed [12] with the exception of the incorporation of the ADI MLT0699 pressure 
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transducer which was placed inline via luer lock connections just downstream of the 
BVM chamber (Figure 2.3).  It was assumed that the addition of the pressure transducer 
to the system would not alter the flow or pressure fluctuations, as the inner diameter of 
the transducer was the same as that of the tubing used throughout that of the BVM 
system.  Water was used in place of growth media for its cleanliness and to avoid the cost 
of wasting expensive media.  Once the system was understood and consistent results 
could be achieved, readings were taken using growth media to ensure that it would 
produce similar results.  Figure 2.4 shows the entire system as it was configured for 
steady flow pressure characterization.  
 
Figure 2.3 Placement of AD Instruments pressure transducer in steady flow (A) and 
pulsatile (B) configurations. 
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Figure 2.4 Steady flow configuration set up for pressure characterization. 
Characterization and Development of the Pulsatile Flow Setup 
 With the pressure profile of the original steady flow setup established, the 
development and characterization of the pulsatile setup commenced.  Initial testing 
involved a simple closed loop of Masterflex L/S 16 tubing driven by the 3-roller pump 
head with the same ADI pressure transducer in place.  This testing was carried out using 
water at an RPM of 20 to simulate a heart rate of 60 BPM.   
In order to pressurize the system and create pulsation, a stopcock was put in place 
downstream of the pressure transducer to regulate backpressure.  Although an increase in 
pressure was seen, there was a subsequent vacuum following each positive spike.  It was 
deduced that this negative pressure spike would be detrimental to the growth of the BVM 
as it could possibly pull the cells off of the scaffold or hinder proper seeding and 
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development.  Thus, a reservoir was added to the simple loop setup just upstream of the 
pump head and downstream of the backpressure stopcock. 
 The follow-up to the initial studies with the simple, closed loop involved the 
incorporation of the BVM chamber.  The chamber was placed in the system just upstream 
of the pressure transducer and downstream of the pump head.  The stopcock remained 
downstream of the pressure transducer to control backpressure in the BVM chamber.  At 
this point, the system was configured exactly as it would be when used to culture the 
BVM including the ePTFE scaffold in the chamber, with the exception of the perfusion 
fluid, which at this point was water (Figure 2.4).  
It was quickly determined that the standard stopcock did not allow for fine 
adjustments in back pressure as there was a very small margin between regulating 
restriction and complete stoppage of flow.  Therefore, a roller clamp was implemented as 
a possible solution.  Instead of acting as an inline flow controller, the roller clamp mounts 
external to tubing and acts by “pinching” the tubing between a roller barrel and an angled 
ramp resulting in a gradual increase in flow restriction.  Not only was it thought that this 
clamp type could better control flow, but it also mounted external to the sterile barrier of 
the tubing, thus reducing the opportunity for contaminates to become lodged in the 
crevices of a stopcock.  
 As a potential improvement over the roller clamp, a ratchet screw tubing 
compressor from Cole Parmer (P/N WU-06833-10 –Figure 2.3) was tested on the ADI 
Powerlab system following the same procedure used for the other two clamps.  Each 
target pressure was indexed on the clamp to allow the settings to be established and set in 
the system without the use of the pressure sensor.  This is desirable, as the system needs 
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to be pressurized in the CO2 incubator where the pressure monitoring system is not 
available (See Appendix A).  One additional feature of the ratchet clamp is that it can be 
attached to up to three tubes at once allowing for identical pressure settings in up to three 
systems at once.  Figure 2.5 illustrates the system as it was set up for pulsatile flow. 
 
Figure 2.5 Pulsatile flow configuration set up for pressure characterization. 
Development of Blood Pressure Model Settings 
 Following the establishment of desired pressure waveforms in the complete BVM 
system, the next step was to attempt to specify settings for several different models that 
would simulate conditions of the cardiovascular system.  One of the benefits of this in 
vitro system lies in its tunability.  Pulse rate and pressure fluctuation can be adjusted 
independently which would allow for modeling of conditions such as hypertension or 
tachycardia. 
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To show that the system can simulate varied physiologic conditions, the flow 
setup was adjusted while monitoring with the ADI Powerlab system to determine the 
settings for three example blood pressure models.  Settings were established for: normal 
adult, mild hypertensive and moderate hypertensive models. Table 2.2 indicates target 
pressure ranges for the each of these models. 
Table 2.2 Target pressures for BVM Blood Pressure Models [80]. 
 
With the pressure waveforms of the fully equipped system validated, pressure readings 
were taken using growth media to establish that the use of media in the system would not 
alter the pressure characteristics found when testing with water. 
 
Preliminary Cell Adhesion Test 
 With the ratchet clamp indexed to produce the desired pressure fluctuations for 
the “normal adult “ pressure range, two BVM setups were prepared to determine if the 
system could maintain long term pressure following the implementation of pulsation.  For 
this initial test, Human Umbilical Artery Smooth Muscle Cells were sodded onto an 
ePTFE scaffold per the Sodding Protocol (Appendix B).  These setups were allowed to 
grow under steady flow for several days to allow establishment of the culture and initial 
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adhesion to scaffold.  After 64 hours of steady flow at ~12ml/min, the system was 
removed from the 8-roller pump and installed on the 3-roller pump head.  The pump 
tubing was moved from a section of small tubing (OD: 4.5mm) to a section of Masterflex 
L/S 16 tubing (OD: 6.0mm) with the larger cartridges (Cole Parmer P/N HV-07519-75) 
used on the 3-roller head.  Flow was initiated at 20 RPM to give a flow of ~18.5 ml/min 
and a pulse rate of 60 BPM.  The ratchet clamp was mounted downstream of the BVM 
chamber on both setups and tightened down on the tubing to initiate pressurization of the 
systems to ~70mmHg and pulsation within the graft. 
Upon reaching full pressurization of the system, it was noticed that the restriction 
in luminal flow intended to create backpressure was causing excessive transmural flow.  
In order to continue the test run, backpressure was reduced to ~30mmHg and the pump 
speed was reduced to 15 RPM to restore luminal flow.  One of the BVM setups was taken 
down after 2 hours of pulsation and the second setup was taken down after 24 hours.  
Once the system was down, the graft was removed and placed in Histochoice to preserve 
it for later analysis.  Due to the problems experienced in these trials, analysis of these 
particular constructs was not performed in this thesis, however the samples were stored 
for potential subsequent studies. 
 
Pressure Testing with First and Second Generation BVM Chambers 
 Due to observed problems with excessive transmural flow during initial cell 
adhesion tests, the flow characteristics were reexamined on the ADI system with greater 
scrutiny.  The original tests were done without considering the rigidity of the BVM 
chamber.  In order to determine if this would affect the excessive transmural flow seen in 
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the initial tests, an older version of the BVM chamber made of rigid polycarbonate with a 
highly secure lid was tested on the ADI system to determine if it would behave similarly 
to the updated chamber. 
Another aspect of the system that was not considered in initial pressure tests was 
the state of the ePTFE graft.  In initial tests, excessive transmural flow may have been 
overlooked, as the graft was not denucleated and thus may have been less permeable to 
the perfusion fluid.  To determine whether or not this was a factor in maintaining luminal 
flow and pressure, pressure tests were done with an ePTFE graft that was denucleated 
(See Appendix B for the cell sodding protocol). 
 
Final Cell Adhesion Tests 
 With the pressurization of the system better understood, more extensive cell 
adhesion tests were performed.  Six grafts were sodded with human umbilical vein 
endothelial cells (HUVECs) and allowed to grow for 72 hours under steady flow.  After 
72 hours, five of the six setups were moved to the 3-roller pump head and for 
comparative purposes, these variable groups were maintained at three different pressure 
settings.  The remaining graft was maintained under steady flow on the 8-roller pump 
head at 15 ml/min for use as a control.  See Table 2.3 for an overview of the test 
conditions.  To avoid disturbing or dislodging the cells from the scaffold, the pump speed 
was reduced to 10 RPM for the initial application of backpressure and pressurization of 
the system.  The ratchet clamp was tightened to a previously indexed setting and the 
pressure was then ramped up incrementally by increasing the pump speed by three RPM 
every hour until the final setting of 20 RPM was established.  Once the final pressure and 
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pump speed were reached, the constructs were maintained at these settings for 24 hours, 
at which point all six setups were taken down. 
Table 2.3 Pulsatile flow cell adhesion test condition summary. 
Group/Construct #
Pump Head 
Used
Final 
Pulsatile 
Pressure 
(mmHg)
Final Flow 
Rate 
(ml/min)
Pump RPM
Time at Final 
Pulse 
Pressure 
(hours)
PA1 8-roller unspecified 15 140 24
PB1 3-roller unspecified 18.5 20 24
PB2 3-roller ~40 18.5 20 24
PB3 3-roller ~40 18.5 20 24
PB4 3-roller ~80 18.5 20 24
PB5 3-roller ~80 18.5 20 24  
To take down the systems, the peristaltic pumps were turned off, stopcocks 
proximal and distal to the graft chamber were closed and the tubing cartridge and tubing 
were removed from the pump head.  If additional systems were to be maintained, the 
pump was restarted at the specified RPM.  With the setup removed from the pump 
system, the chamber was opened and the scaffold was carefully cut at both ends using a 
No. 11 scalpel blade while still submerged in media.  Without compressing or bending 
the scaffold, it was then placed in a vial of Histochoice for preservation until later 
analysis with SEM and bisbenzimide (BBI) staining (see Figure 2.6).  When placing the 
excised graft in the fixative, the orientation of the graft was marked as to keep track of 
the distal and proximal ends for analysis purposes.  The media was drained from the 
chamber and the tubing and all parts were washed for reuse. 
When all grafts had been in Histochoice for at least 24 hours at room temperature, 
a portion of the distal end of the fixed graft was cut off.  This section was then cut 
longitudinally in order to separate the upper and lower hemispheres of the graft.  These 
sections were then placed in 1:1000 dilution of BBI stain.  After 24 hours in this solution, 
the samples were analyzed under a fluorescent microscope. 
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Figure 2.6 Removal of ePTFE graft from BVM bioreactor chamber upon 
completion of growth period. 
 After BBI imaging was completed, the sections were placed in a dessicator 
overnight to dry them out in preparation for Scanning Electron Microscopy (SEM).  Once 
dry, the samples were gold sputter coated for 70 seconds and analyzed in the SEM. 
 
RESULTS 
Estimating Flow Rates 
 The following flow rates were obtained from Cole Parmer (Table 2.4).  These 
data were plotted and the resulting linear equations (Figure 2.7) were used to estimate the 
flow rates at different pump speeds (Table 2.5 and Figure 2.8). 
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Table 2.4 Data for initial comparison of potential pump configurations. 
 
 
Figure 2.7 Plot of manufacturers estimated flow rates with linear approximations. 
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Table 2.5 Flow rates estimated using linear equations extrapolated from 
manufacturer's data.  Blue highlighted flow rates correspond to those specified in 
the configuration in the original system. 
 
 
Figure 2.8 Plot of estimated flow rates using different pump tubing diameters. 
Based on the estimated flow rates seen in Table 2.5 the Masterflex L/S 16 sized tubing 
showed the most desirable characteristics when paired with the 3-roller pump head.  The 
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L/S 16 tubing has an outer diameter of 6.0mm and an inner diameter of 3.1mm.  This 
tubing was selected for use in the pulsatile BVM system for its ability to produce the 
desired flow rates (highlighted in blue in Table 2.5 at the corresponding desired pulse 
rates). 
 
Actual Flow Rate vs. Pump Speed 
The results of the flow rate tests can be seen below in Table 2.6 and Figure 2.9.  
For a comparison of the estimated and actual flow rates see Figure 2.10.  Due to the 
larger diameter of the pump tubing used in the pulsatile design, a much lower RPM was 
required in the pulsatile setup to produce desired flow rate.  This was desirable as it 
produced appropriate pulse rates that corresponded to physiologic conditions as 
compared to the high pulse rates using the 8-roller head. 
Table 2.6 Actual flow rates of steady and pulsatile flow configurations. 
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Figure 2.9 Plot of actual flow rates of 3 and 8 roller pump heads in Table 2.6. 
 
Figure 2.10 Estimated vs. actual flow rates using 3-roller pump head. 
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Although the actual flow rates were higher than those predicted using the manufacturers 
data for L/S 16 tubing, they were relatively close, demonstrating that not only does the 
system produce appropriate flow rates at desired pulse rates, but also the decision to use 
L/S 16 tubing was appropriate. 
 
Pressure Fluctuation Tests 
Characterization of Original Steady Flow Configuration 
As expected, the small tubing and 8-roller pump head produced a pressure profile 
with consistently small fluctuations at very high pulse rates (Figure 2.11).  The same 
setup was then tested using growth media in the system instead of water.  Although this 
waveform is not shown, the use of media did not alter the resulting pressure profile. 
 
Figure 2.11 Pressure profile of steady flow setup at ~11ml/min. 
The steady flow setup was tested at different pump speeds to determine how the luminal 
pressure was affected.  There was an observed increase in pressure levels in the system.  
However, this increase was not uniform, with a sharp decrease seen at higher RPMs, an 
issue possibly due to cavitations in the tubing at the pump head (Table 2.7 and Figure 
2.12). 
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Table 2.7 Measured flow characteristics of steady flow configuration. 
 
 
Figure 2.12 Plot flow characteristics of steady flow setup with 8-roller pump from 
data in Table 2.7. 
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Characterization of Pulsatile Setup 
 Initial Testing with Closed Loop 
The initial testing of the pulsatile setup with the 3-roller pump head and simple 
closed loop of L/S 16 tubing indicated the presence of a vacuum following the positive 
pressure spike.  This was remedied by the addition of the media reservoir to the system 
between the pump and stopcock (Figure 2.13). 
 
Figure 2.13 Pressure profiles of closed loop with 3-roller pump at ~18.5 ml/min 
using a ratchet clamp downstream of pressure transducer to create backpressure.  
Note the presence of a vacuum in top graph that was remedied by the addition of the 
media reservoir as seen in the bottom profile. 
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Addition of BVM Chamber  
Pressure profiles were obtained following the addition of the BVM chamber to the 
closed loop setup.  This setup showed similar results to the simple loop with the reservoir 
(Figure 2.14).  
 
Figure 2.14 Pressure profile of system with BVM chamber and 3-roller pump at 
~18.5 ml/min with ratchet clamp downstream of the pressure transducer to create 
backpressure. 
System Pressure with Water vs. Media 
The complete system was then tested with water and media using backpressure 
and pump speeds setting to ensure that the use of media would not significantly alter the 
pressure profile of the system.  There was no observed change caused by the introduction 
of media to the system (Figure 2.15). 
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Figure 2.15 Comparison of perfusion fluids in complete pulsatile system at ~18.5 
ml/min. 
 Establishing Back Pressure 
Use of the roller clamp provided similar results upon initial testing and identical 
pressure waveforms as those obtained with the stopcock.  However, when an attempt was 
made to establish settings for various flow models, the roller clamp posed similar 
difficulty in allowing for small variations in pressure.  Although this was an improvement 
over the stopcock, the ratchet clamp was investigated as a means of improving the ability 
to fine-tune the pressure settings.  The ratchet clamp proved to be the most user-friendly 
of the three, however, adjustment of the pressure ranges were still not as indexable as 
desired as very small adjustments of the clamp caused large changes in system pressure.  
See Figure 2.16 for the tested devices.  As a result, a single applicable clamp setting was 
set using the pressure measurement system and desired pressure and flow was adjusted 
via pump speed only. 
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Figure 2.16 Tested options for creating backpressure.  (A) Stopcock, (B) Roller 
Clamp, (C) Ratchet clamp. 
The flow rates and pressure readings were measured in the pulsatile setup to 
determine the pressure endpoints at different pump speeds.  Although pump speed and 
pressure can be adjusted independently in this system, the backpressure was left constant 
during these tests in order to simplify the setup. Contrary to the steady flow setup using 
the 8-roller pump head, luminal pressure increased steadily relative to pump speed (Table 
2.8) and with the backpressure setting left unchanged, the system pressure increased with 
pump speed, but the measure flow rates and waveforms remained similar (Table 2.8 and 
Figure 2.17). 
Table 2.8 Measured flow characteristics of complete pulsatile system with ratchet 
clamp in place. 
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Figure 2.17 Plot of flow characteristics of pulsatile setup from data in Table 2.8. 
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Figure 2.18 Pressure profiles with constant backpressure and varied pump speed. 
As seen in the plots above in Figure 2.18, the waveforms of the 10 and 15 RPM 
settings appear different than the 20-35 RPM settings.  These recordings were done using 
identical system configurations with the only variable being changes in pump speed.  The 
difference in the first two waveforms is most likely time dependent as the increased 
pressure at these settings had to be maintained over the same period with the flattened, 
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wavy peaks indicating that the system pressure was held at the elevated level between 
pulses.  
 
Pressure Differentials: Cardiac vs. BVM 
BVM pressures were compared to those found as a result of native cardiac outputs 
in patients with varied degrees of hypertension (Table 2.9 and Figure 2.19).  This 
comparison allows for the use of the BVM as a model of disease conditions by simply 
increasing the pump speed while leaving the backpressure setting constant.  Due to the 
fact that the BVM system is open and thus cannot maintain a baseline pressure, the 
minimum pressure, and therefore, the pressure differentials in the BVM system are not 
significantly similar to native conditions (Figure 2.20).  However, the maximum 
pressures seen in the BVM lumen showed similar increases as the native systolic 
pressures found in varying degrees of hypertension.  This is important, as the peak 
pressure is responsible for the cyclic wall strain that was previously described as having 
great importance in vessel development. 
Table 2.9 Comparison of cardiac blood pressure conditions and flow settings in 
pulsatile BVM system (blood pressure figures taken from [80]. 
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Figure 2.19 Comparison of BVM vs. native cardiac pressures. 
 
Figure 2.20 Comparison of BVM vs. native cardiac pressure differentials. 
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Preliminary Cell Adhesion Test 
After running a HUVSMC-sodded vessel for several minutes under pulsatile flow, 
it was noticed that the fluid level in the media reservoir was dropping, indicating a 
problem with the return flow.  Upon examination, it was assumed that because 
pressurization and pulsation relies on restricting luminal flow, the increased pressure seen 
at the porous graft was resulting in transmural flow rather than maintaining pulsatile 
luminal flow.  It was assumed that this might be a result of the compressible air in the 
headspace of the BVM chamber. 
 Since no immediate solution was possible without disrupting the system, the 
pressure and pump speed were reduced to ~30mmHg and 15 RPM in an effort to allow 
relief of the backpressure via luminal flow only.  After running for several minutes at 
these new settings, there was no apparent drop in the media level in the reservoir.  One of 
the BVM setups was taken down after running for 2 hours under pulsatile flow at 
~30mmHg to allow for assessment of the construct after exposure to pulsatile flow for a 
relatively short time period. 
The second of the two setups was maintained at ~30mmHg and 15 RPM 
overnight.  Because the empty headspace of the BR chamber was thought to be a cause of 
the excessive transmural flow, it was filled with media for the overnight run.  The next 
morning it was noticed that the level of the media reservoir had dropped below the draw 
tube and the tubing of the BVM system and graft did not contain any media.  A leak was 
discovered that later was determined to be a breach in the seal of the lid of the BVM 
chamber.  It is unknown how long the system was in this state.  When this leak was 
discovered this setup was immediately taken down. 
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All grafts taken down following this preliminary test were placed in Histochoice 
to preserve them.  However, due to the problems experienced with excessive transmural 
flow and leaking, these samples were not analyzed as it was assumed that the resulting 
data could not be used to draw any valuable conclusions. 
 
Follow-up Pressure Tests 
 The systems were retested on the AD Instruments LabChart system and it was 
determined that the pressurization of the extra-luminal chamber was caused by backflow 
through the extra-luminal outlet.  This was remedied by placing a tubing clamp on the 
outlet tubing that could be tightened following the sodding procedure.  The tests with the 
denucleated graft showed no change in waveforms or the ability to sustain pressure.  As 
an additional check, the system was run at target pressures with no fluid in the extra-
luminal space to visually assess the degree of transmural flow.  No transmural flow was 
detected under these conditions.  As a final confirmation of the system’s ability to 
maintain consistent pressure over extended periods of time, the system was configured 
and ran as it would be for pulsatile graft cultivation while monitoring system pressure 
with the ADI system for 4 hours.  Although this result is not shown, there was little 
variation in system pressure from the beginning to the end of the test. 
 
Final Cell Adhesion Tests 
 The setup of the six BVM constructs proceeded without difficulty.  Each graft 
was sodded with approximately 7 x 106 cells, providing a sodding density of ~1.6 x 106 
cells/cm2.  When inserting the graft into the chambers of constructs PA1, PB3 and PB4, it 
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was noticed that the graft had to be somewhat stretched causing it to be under tension 
once in place.  It was unknown how this would affect the sodding or cultivation.  See 
Figure 2.21 to understand construct name codes. 
 
Figure 2.21 Explanation of construct naming scheme. 
 The initial 72-hour growth period under steady flow conditions at 15ml/min was 
completed without any major complications and after 72 hours, the variable groups were 
transferred to the 3-roller pumps and the systems were pressurized to initiate pulsatile 
flow under the conditions outlined in Table 2.3.  When changing construct PB3 over to 
pulsatile flow, it was noticed that the small diameter pump tubing used in the initial 
steady flow growth period had developed a minor crack resulting in a slight leak.  This 
did not result in any significant loss of media volume.  The complications experienced 
when pressurizing the system in the preliminary cell adhesion tests were not seen in this 
trial, allowing all five of the pressurized variable groups to run for 24 hours without any 
problems.  In order to achieve the desired pulsation pressure, the backpressure clamp had 
to be carefully adjusted while observing the media return flow and the resulting clamp 
settings were consistent among all four of the pressurized systems. 
 After 24 hours of pulsatile flow, all bioreactor systems were taken down.  Before 
removing the bioreactor systems from the incubator it was noticed that PA1 and PB4 had 
developed significant airspace (bubbles) in the graft that may have prevented the dorsal 
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(upper) hemisphere of the graft from being fully immersed in media.  It is unknown how 
long this condition existed. 
 BBI imaging showed that cells remained on all six grafts following exposure to 
steady flow as well as the varying levels of pulsation (Figure 2.22-Figure 2.25).  This was 
confirmed by SEM imaging and although all constructs indicated the presence of cells on 
the scaffold, the number of cells present varied.  For purposes of the analysis presented 
here, cell coverage on the grafts was assessed on a qualitative basis by estimating 
coverage as percentage of the overall surface. 
Analysis of construct PA1, the 8-roller steady-flow control setup, indicated that 
cells were present following the four-day cultivation period, however surface density was 
not as extensive as expected (Figure 2.22).   This result may have been due to the tension 
under which the graft was installed in the bioreactor.  BBI imaging of this construct 
indicated a considerable number cell nuclei present.  However, when visualized under 
SEM, the cell density on the graft surface did not correspond with this result, as surface 
coverage was somewhat sparse.  There was, however, some indication of cell spreading 
and/or matrix deposition by the cells that remained on the surface. 
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Figure 2.22 BBI(A) and SEM(B) imaging of construct PA1 (96 hours of steady flow 
@ 15ml/min). 
 
Figure 2.23 BBI(A) and SEM(B) imaging of construct PB1 (72 hours of steady flow 
on 8-roller pump @ 15ml/min and 24 hours of steady flow on 3-roller pump). 
The 3-roller control setup, construct PB1, produced a graft with an increased 
surface cell density compared to the PA1 construct.  The BBI results in Figure 2.23 show 
a similar number of nuclei to those in Figure 2.22, but there was a moderate increase in 
the number of cells on and in between the nodes of the ePTFE graft of the PB1 construct 
(Figure 2.23). 
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Constructs grown under 24 hours of pulsation indicated an increased surface cell 
density as well as more extensive cell extension and/or matrix deposition.  This was most 
evident in construct PB2, which was exposed to ~40mmHg pulsatile flow for 24 hours.  
As seen in Figure 2.24, there were more, larger cell nuclei than those in the control 
construct PA1 and PB1.  The surface cell density was also noticeably higher in the SEM 
image of PB2 and there was an apparent increase in cell extension and/or matrix 
deposition as indicated by the fibrous tendrils extending across the nodes. 
Imaging of the constructs grown under 80mmHg pulsatile flow indicated that the 
cells remained on the graft following 24 hours of exposure to the increased level of 
pulsation (Figure 2.25).  The BBI image of the PB5 construct showed a similar number of 
nuclei as the control groups, however there was a noticeable increase in surface cell 
density and cell extension and/or matrix deposition as seem in the SEM image.  For more 
construct images See Appendix A. 
 
Figure 2.24 BBI(A) and SEM(B) imaging of construct PB2 (72 hours of steady flow 
on 8-roller pump @ 15ml/min and 24 hours of pulsatile flow on 3-roller pump at 
18.5 ml/min and ~40mmHg). 
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Figure 2.25 BBI(A) and SEM(B) imaging of construct PB5 (72 hours of steady flow 
on 8-roller pump @ 15ml/min and 24 hours of pulsatile flow on 3-roller pump at 
18.5 ml/min and ~80mmHg). 
  
DISCUSSION 
Development of Pulsatile System 
The primary aim of the work discussed in this chapter was to develop and 
implement pulsatile flow in the BVM bioreactor system with the intention of creating 
flow conditions similar to those experienced by native vessels in order to eventually 
improve the phenotypic expression of human blood vessel cells grown in vitro.  Due to 
the fact that this system was originally designed to be a simple, high throughput-testing 
environment for coronary stents, the development of pulsatile flow was approached with 
the goal of maintaining the original system’s simplicity and potential for scale-up.  This 
work was intended to be used as groundwork for the development of an ideal bioreactor 
system that can be used to produce native-like BVMs.  Since this system had not yet been 
tested under pulsatile conditions, the specific objective of this portion of this thesis was to 
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determine if a BVM construct could be cultivated in this system with the addition of 
pulsatile flow while maintaining cell adhesion. 
The original system was configured for steady, perfusive flow via a peristaltic 
pump that relied on small diameter pump tubing and an eight roller pump head to 
produce many small pulses to drive flow.  Testing of this system demonstrated that the 
pressure waveform was not desirable as it oscillated between equal positive and negative 
values at a rate of ~6 Hz or 360 beats per minute.  The initial thought was that pulsatile 
flow could be established with minor alterations to this previously established system.  
These changes included using a different pump head with fewer rollers and larger pump 
tubing; a combination that ultimately produced larger pressure fluctuations at desired 
flow rates and a lower pulse rate.   
To determine which pump head/tubing configuration would provide the desired 
conditions, the system was tested with a data acquisition system that measured real-time 
system pressure.  This allowed different configurations to be tested and adjusted until a 
desired waveform was established.  The initial choice of the pump head and tubing was 
based on flow rate and pulse rate.  The thought was that if the desired flow rate could be 
established using a configuration that would concurrently run at a desired pulse rate, the 
application of backpressure downstream of the growth chamber could be used to create 
and adjust pressurization of the system.  After testing several methods for applying the 
backpressure, an external tubing clamp was chosen and although this method effectively 
created desired waveforms, the pressure was not as adjustable as originally desired.  This 
aspect of the system will require further development to allow for more finely tunable 
system pressure. 
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Scalability 
Along with maintaining simplicity, another aspect of the BVM system taken into 
consideration during the development of pulsatile flow was scalability.  The changes 
made to the system to achieve pulsation did not affect the overall configuration of the 
system to any great degree as it involved the addition of larger diameter tubing and the 
use of a different pump head.  The only aspect that may affect scalability is the number of 
constructs that can be driven by each pump.  The original system’s eight roller pump 
head can drive up to twelve systems at once while the 3-roller head configured with the 
large tubing cartridges used in this study can house only four systems making incubator 
space more of a concern (See Appendix A). 
 
Comparison to Previous Work 
The implementation of pulsatile flow in a TEVG bioreactor system is not a novel 
achievement.  Although other groups have succeeded in creating systems that accomplish 
this, the methods used are typically more involved and complex [28,29,85].  These 
systems incorporate multiple pumps, flow meters and flow controllers to create 
physiologic pulsation.  The use of these devices may allow for more finely tunable 
pressure fluctuations that can be constantly monitoring during cultivation, however the 
added complexity may also bring about more complications.  By establishing pulsatile 
flow using the methods described in this thesis, there are fewer opportunities for 
contamination and/or problems that may result from device failure in a large-scale 
application such as ours. 
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Cell Adhesion 
The final step of this work was to determine whether or not a BVM construct 
could be cultivated under pulsatile flow using the methods described above.  As this was 
preliminary work in establishing pulsatile flow, the primary goal was to find out whether 
or not the sodded cells would maintain adhesion to the scaffold after exposure to pulsatile 
pressures.  Due to the fact that there was not a large enough sample size to make 
statistically significant claims, no conclusive statements can be made as to the conditions 
that will provide optimal growth and cell morphology.  However, for purposes of this 
thesis, it can be concluded that the methods developed here can be used to cultivate a 
BVM construct under pulsatile flow conditions and that the sodded cells will maintain 
adhesion to the ePTFE scaffold at peak pressures of ~80mmHg for up to 24 hours. 
Although the cell adhesion test indicated the presence of cells following 
cultivation, there were some notable observations and assumptions made based on the 
results.  As mentioned above, the surface density of the steady flow control construct 
(PA1) was unexpectedly low.  This was further questioned when the density on the 
surface of the pressurized variable groups was found to be considerably higher.  Because 
the BBI image of this construct indicates the presence of cell nuclei, the only discrepancy 
that could explain this result is the tension placed in the scaffold when it was installed in 
the chamber.  The fact that there were nuclei present, but very few cells on the surface 
may indicate that the stretching of the ePTFE, which was transverse to the nodal 
orientation of the material, may have expanded the internodal spaces allowing the cells to 
be pushed deeper in the pores making them indistinguishable under SEM.  To determine 
if this is the case, further analysis should be performed. 
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Construct Appearance and Cell Morphology 
 While analysis of the cell adhesion test constructs indicated the presence of cells, 
the resulting morphology when visualized under SEM was questioned, as there was no 
confluent monolayer that would be expected from cultivation of endothelial cells.  Again, 
the sample size was not large enough to make any substantial claims regarding this result.  
However, because our lab did not have a great deal of experience culturing HUVECs, the 
growth characteristics of this cell type were investigated and based on the results of 
several other groups, there could be several explanations for the resulting morphology 
that may provide some suggestions for methods used in future work with this cell type.  
Prior experience with Human Microvessel Endothelial Cells (HMVECs) grown in the 
BVM system led to the expectation that surface morphology would appear as it does in 
Figure 2.26.  However, a study by Hsu et al into the growth of HUVECs in a perfusion 
bioreactor resulted in the morphology displayed in Figure 2.27 [31].  When compared to 
the micrographs of the constructs resulting from the work in this thesis, the morphology 
is somewhat similar.  The Hsu construct was cultivated on a polyurethane scaffold rather 
than ePTFE which may account for the difference in appearance, however the possibility 
that the unexpected morphology in our results is a characteristic of the HUVEC 
phenotype cannot be ruled out without further investigation. 
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Figure 2.26 BBI(A) and SEM(B) images of ePTFE graft sodded with HMVECs.  K. 
Cardinal, unpublished data. 
 
Figure 2.27 SEM images of HUVECs cultivated in a perfusion bioreactor system on 
a polyurethane graft [31]. (Permission to reprint figure granted by Elsevier 
publications.  See Appendix D) 
In addition to the possibility that the appearance of the grafts grown under the 
conditions described above was due to the cell type used, this result may also have been 
partially due to the qualities of the scaffold material.  As is characteristic of ePTFE, there 
is little potential for radial distension as a result of the luminal pressure fluctuations.  This 
may have prevented the cells from being exposed to the strain that is the ultimate goal of 
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pulsatile flow.  Although this strain has been shown to primarily affect the growth of 
SMCs, it has also been found to improve EC growth to some degree [41,58,62,68]. 
While the lack of compliance may have limited the beneficial effects of pulsation, 
it may have also amplified its potential for negatively affecting construct growth.  Due to 
the lack of scaffold compliance, the cyclic increases in luminal pressure may not have 
been relieved, resulting in compression of the cells against the scaffold.  This possibility 
may explain both the poor cell morphology as well as the observation that the cells 
appeared to be lodged further in the internodal spaces than was expected.  Currently, 
there are efforts to develop a scaffold for use in the BVM bioreactor system that will 
allow for the compliance necessary to expose sodded cells to the cyclic strain required to 
produce an ideal construct. 
 68 
CHAPTER 3: ESTABLISHING AND CONTROLLING WALL SHEAR STRESS  
 
INTRODUCTION 
 As described in Chapter 1, wall shear stress experienced by the endothelial cells 
of blood vessels can have a profound effect on nearly every aspect of the vessel: cell 
phenotype, cell orientation, and even development and progression of certain diseases 
and conditions [37,42,45,48,74,76,86].  Before presenting the methods and results of this 
work, it is necessary to discuss some basic principles of shear stress in fluid flow, the 
physiologic importance of shear stress, the level of shear required to produce desired 
effects, the methods by which other groups have implemented shear stress in their 
systems, and the concept behind developing the desired shear stress in our model. 
 
Physics of Shear Stress in a Tube 
In the case of fluid flow, viscous or wall shear stress is the tangential force 
experienced by a solid boundary when the fluid flows past it.  The properties of the fluid, 
the geometry and properties of the boundary surface and the characteristics of the flow 
itself can affect the wall shear stress experienced at the boundary [17,82].  Due to the fact 
that the scaffold material and geometry are essentially fixed in this study, these variables 
will be considered constant and wall shear stress will be addressed by considering only 
the fluid’s viscosity and flow rate.  Although there are many other possible factors to 
consider such as the pressure gradient across the diameter of the tube, the resistant 
properties of the tube material and varied geometries of the tube, this is beyond the scope 
of this work. 
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Dynamic viscosity is the force per unit area required to move two horizontal 
planes past one another when the two planes are separated by constant distance [19].  In 
the case of the BVM, the two horizontal planes are the wall of the graft and the plane 
created by the perfusate flow.  In this case, the calculated dynamic viscosity will be 
considered to be the same over the entire inner circumference of the graft surface.  The 
international system (SI) unit of dynamic viscosity is the Pascal-second (Pa•s) while the 
centimeter-gram-second (CGS) unit is the Poise (P) [17].  For purposes of this study, 
viscosity will be referred to in centipoise (cP), which is equal to 0.001 Pa•s [2].  The SI 
unit for shear stress is the Pascal (Pa), but for purposes of this work, shear stress will be 
referred to in dyne/cm2, or 0.1 Pa [2]. 
 
Effects of Shear Stress on Blood Vessel Physiology 
Proper phenotypic expression and alignment of vascular cells is significantly 
dictated by the shear forces experienced by the cells and therefore, the characteristics of 
flow within the vessel [37,42,45,48,74,76,86].  Shear stress aids in regulating phenotype 
by altering gene expression, which results in changes in the release of growth factors and 
adhesion molecules [45].  This can affect the cells on an individual, morphologic level as 
well as on the tissue level with observed changes in cell organization and grouping 
[18,37,45]. 
Lee et al investigated the effects of shear stress on cell and stress fiber orientation 
in smooth muscle cells (SMCs) isolated from the coronary arteries of dogs [42].  They 
also aimed to determine the magnitude of shear and time required to illicit cellular 
responses in order to gain an understanding of the mechanism that drives this response 
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[42].  By culturing the isolated cells in a shear-controlled environment, they found that 
increased shear stress influences the alignment of SMCs and, contrary to studies on the 
alignment of ECs, SMCs were found to arrange themselves perpendicular to flow [42].  
This alignment was found to be dependent on stress magnitude as well as exposure time 
[42].  While cultures grown for 0-48 hours under static or 1 dyne/cm2 conditions did not 
show signs of organized alignment, shear stresses between 10-20 dyne/cm2 induced 
perpendicular orientation with the greatest degree of alignment resulting from exposure 
to the higher end of this range [42].  Additionally, the degree of alignment was found to 
be time-sensitive as orientation became perpendicular to flow more quickly (within 4 
hours) at 20 dyne/cm2 and more extensive with longer exposure times, with the greatest 
alignment occurring after 48 hours of exposure [42].  Although a specific mechanism was 
not identified that directly controls the SMCs response to the shear stress, fluorescent 
staining of the cultures grown under increased shear revealed increased levels of 
perpendicular alignment of F-actin microfilaments compared to those grown in static 
conditions [42]. 
In a study performed by Malek et al, confluent BAEC monolayers were cultivated 
in a 20 dyne/cm2 shear stress environment for 24 hours and then analyzed for 
morphology, orientation, presence of actin fibers, β-actin mRNA levels, and intracellular 
enzyme activity [45].  Microscopic visualization indicated a change from the 
“cobblestone” appearance of static EC cultures to a uniform alignment in the direction of 
flow when grown in increased shear conditions [45].  Similarly, actin fiber staining 
showed that the actin fibers that were radially arranged around the individual cells in 
static cultures formed “cables” directed parallel to flow [45].  This morphologic 
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observation was further supported by the detection of increased levels of intracellular β-
actin mRNA [45].  Intracellular calcium levels and tyrosine kinase (TK) activity were 
also found to affect morphologic changes [45].  When static cultures of BAECs were 
treated with calcium chelators such as BAPTA-AM, the shape of these cells was altered 
[45].  Additionally, when cells grown in increased shear were treated with herbimycin A, 
an inhibitor of TK, the morphologic changes and actin fiber formation were not observed 
[45].  The specific mechanisms by which calcium and TK act were not determined. 
It has been demonstrated that endothelial cells (ECs) align parallel to the direction 
of flow when the perfusion fluid generates shear forces of 6-10 dyne/cm2 [48].  The 
mechanism for this is not well understood, but within 25 minutes of exposure to 
increased shear forces lamellipodae and “stress fibers,” that showed random orientation 
about cells in static cultures became organized into “cables” that were parallel to the 
direction of flow.  Masuda et al did not state it, but because these stress fibers contain 
actin, orientation may be facilitated by the fibers pulling the cell body in the desired 
direction in response to sensed shear stresses.  Although viscous stress mainly affects 
endothelial cells due to the direct contact, it has also been shown to affect the alignment 
of smooth muscle cells (SMCs) [42].  When exposed to stresses above 10 dyn/cm2, SMCs 
were observed to self-orient themselves perpendicular to the direction of fluid flow [42].  
This finding is consistent with the observed SMC orientation induced by cyclic radial 
distension that results from pulsatile flow [42]. 
Along with its influence on individual cell orientation and phenotype, shear stress 
affects the physiology of the vessel as a whole, with the manifestation and progression of 
conditions such as coronary artery disease and restenosis [37,46,74,83].  Using the same 
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cellular mechanisms, this effect has also been characterized as the endothelial layer’s 
atheroprotective response in regions of higher shear stresses [48].  By observing different 
regions of the vasculature while considering the flow patterns typical to that region, 
investigators noted that regions where shear stress was laminar and constant, there was 
less of a tendency to develop atherosclerotic tissue, indicating that a protective 
mechanism had also been activated in the endothelial layer [45,76].  The opposite was 
also shown to be true in regions where shear stress was typically variable and turbulent, 
with a mean stress of less than 6 dyne/ cm2, there was a higher instance of atherosclerotic 
plaque formation [76].  For purposes of this thesis, the observed effects that shear stresses 
have on vascular cells confirms the need to establish physiologic shear stress in our BVM 
system in order to create a native-like construct. 
 
Importance of and Minimum Shear Stress Required for Cell Alignment 
 With it understood that shear stress is a significant factor in the proper 
development of vascular cells and blood vessels as a whole, it is necessary to discuss the 
degree of shear stress that must be imposed on our system to produce the best possible 
construct.  Although no absolute minimum shear stress requirement could be determined 
from existing studies, there was a general consensus on the approximate range of stress 
necessary for EC and SMC alignment; from 6-10 dyne/cm2 [18,25,28,42,45,48]. 
One study investigated the effects of shear on endothelial progenitor cells (EPCs) 
[86].  It was found that EPCs respond to stresses as low as 0.1-2.5 dyne/cm2 [86].  Video 
analysis showed that confluent layers of EPCs exhibited signs of alignment parallel to 
flow within 10 minutes of exposure to shear stresses ~2 dyne/cm2 [48].  After one hour of 
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exposure to the same stress level, ~70% of the cells’ lamellipodae (stress fibers) had 
become aligned downstream and parallel to flow and after 24 hours the cells themselves 
had oriented their long axes in a similar manner [48].  Furthermore, it was observed that 
the alignment of the cells and their lamellipodae became random when shear stresses 
were reduced to stasis [48].  Although EPCs are not directly relevant to this thesis, their 
response is notable as it reinforces the need for a proper shear environment and may 
provide a basis for future work in our lab. 
Among the research reviewed for this thesis, there is conflicting data regarding 
the minimum shear stress required to produce an ideal, native-like blood vessel construct.  
There is a common range, however, of 6-10 dyne/cm2 [18,28,37,42,45,48,74,76,86].  For 
purposes of this thesis, the target shear stress will be 6-8 dyne/cm2 as the low flow rate 
and diameter of the graft make achieving the higher side of this range (9-10 dyne/cm2) 
difficult without making the viscosity of the media abnormally high. 
  
Previously Used Methods for Implementing Wall Shear Stress (WSS) in TEVGs 
 Among the many studies on the effects of shear stress on the alignment and 
organization of vascular cells, the most common method for introducing shear forces to 
cell cultures involves the use of a parallel-plate flow system [18,42,48,86].  Some work 
has been done using a perfusion system similar to ours however; the objective of most of 
these studies does not focus directly on the morphologic and physiologic activity of 
vascular cells but rather on the development of a viable TEVG [37,25,28]. 
 Masuda et al designed a system that aimed to characterize the alignment and 
morphologic response of bovine carotid arterial endothelial cells with real-time analysis 
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[48].  The ECs were plated onto glass substrates, which were placed in a flow chamber 
that was equipped for video microscopy [48].  A peristaltic pump was used to drive the 
flow of the growth media, which was amended with polyvinylpyrolidone or 
methylcellulose to increase the viscosity [48].  The resulting viscosity of the media was 
not specified, but it is assumed that the shear stress was primarily controlled by adjusting 
the flow rate and distance between the glass plates.  In addition to the need for shear 
stress in order to induce alignment of ECs, the key finding from this study was that 
cultures should consist of confluent monolayers when applying shear stresses, as it was 
found that sparsely cultured ECs exposed to ≥6 dyne/cm2 did not align with flow even 
after 100 hours of exposure [48].  This finding is relevant to the current thesis work as it 
presents the need to use low shear conditions during the sodding period and allow a 
confluent monolayer of cells to become established on the scaffold prior to introducing 
increased shear stress to the system. 
 Using a system similar to that of the Masuda group, Davies et al examined the 
effects of laminar versus turbulent flow under increased shear conditions on EC growth 
[18].  Bovine aortic endothelial cell monolayers were grown on glass coverslips in a 
modified cone-plate viscometer [18].  Shear stress in their system was controlled by 
adjusting the media flow rate and the distance between the growth plates [18].  Consistent 
with other studies of this type, normal growth and proper alignment (parallel to fluid 
flow) were observed in cultures subjected to shear stresses ~8 dyne/cm2.  An important 
result of this work was the observation that along with suitable shear stress, laminar as 
opposed to turbulent flow is also a requirement for proper growth.  Even with shear 
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stresses up to 14 dyne/cm2, if the flow was turbulent, the cell orientation became random 
and there was observed cell retraction and loss from the initial monolayer [18]. 
 Koller et al used a TEVG style perfusion bioreactor system to investigate the 
effects of shear stress and flow on the dilation of arterioles [37].  First-order, 10-40 µm 
diameter, arterioles were isolated from six-week old Wistar rats and placed directly in a 
perfusion chamber by attaching micropipettes to each end of the vessel [37].  Pressure in 
the system was held constant at 60mmHg [37].  Dextran (MW 77,800) was added to the 
media at concentrations of 0, 2, 4 and 6% to produce viscosities of 0.9, 1.35, 2.23 and 
3.16 centipoise respectively [37].  The wall shear stress, which ranged from 0-470 
dyne/cm2, was calculated using τwall = 4µQ/πr3 [37].  The results presented by Koller et al 
indicated that arterioles dilate in response to increased shear forces, a finding that is 
consistent with native vessel response [37]. 
 Guidicandrea et al presented a study that aimed to develop what they termed an 
“Ideal Flow Circuit” which was used to characterize the response of endothelial cells that 
were seeded onto grafts.  The perfusion system they developed was quite complex as it 
had analysis probes that provided real-time feedback on the pH, pO2 and pCO2 levels of 
the circulating media [25].  These levels were automatically adjusted by an oxygenator, 
mounted inline, with temperature control via a heat exchanger [25].  A pressure control 
system monitored and adjusted pulsation in the system by opening and closing a set of 
solenoid valves mounted inline [25].  Investigators made it clear that shear stress was 
essential in the development of their “ideal” system and relied on the addition of Dextran 
(MW 77,000) to increase the viscosity of their media.  This allowed for the establishment 
of physiologic shear stresses of ~7.6 dyne/cm2 with flow rates around 212 ml/min [25].  
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The study did not present any direct results regarding cell alignment or morphology, but 
they indicated that this shear stress improved cell retention on the graft and that the ECs 
present were more “normal” than those seen under lower shear stresses [25].  They also 
concluded that their system accurately simulates native conditions and could be used to 
study the behavior of ECs under varying conditions [25]. 
     
Wall Shear Stress in the BVM System 
 Without changing the geometry or composition of the scaffold, the fundamental 
methods for increasing and controlling wall shear stress in our BVM will involve 
adjusting flow rate and/or the viscosity of the fluid itself.  Due to limitations of the 
current BVM system, appropriate wall shear stress cannot be achieved by simply 
increasing the flow rate, as the viscosity of the media is near that of water.  Therefore, the 
composition of the media will be manipulated to control the shear stress sensed by the 
cells.  The use of Dextran and Methylcellulose as media additives that increase the 
viscosity and thus wall shear stress has been shown to be suitable for use in vascular cell 
and TEVG cultivation [25,37,48].  Although it has not been used extensively for viscosity 
control in TEVG cultivation, Methylcellulose has been shown to have no adverse effects 
on endothelial cell cultures [19]. 
 As with the development of pulsatile flow in our system, the implementation of 
shear stress was approached with the objective of achieving physiologic wall shear forces 
without making any major changes to the fundamental design, setup and operation of the 
BVM system.  Due to the flow parameters established in the original system, there was 
limited flexibility in adjusting the luminal flow rate, as cell adherence to the ePTFE 
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scaffold is sensitive.  The original system’s flow rate of ~15 ml/min is relatively low 
when compared to other TEVG bioreactor setups such as those described above [12].  
Thus, the approach taken here was to rely mainly on altering the viscosity of the 
perfusion fluid to increase shear. 
 The initial thought when approaching this objective was to simply add a 
thickening agent to the media in a concentration that would provide the desired viscosity 
and corresponding shear stress.  Before attempting to evaluate the effects of shear stress 
in the BVM system, the first step was to determine whether or not these additives would 
be capable of adjusting viscosity to an appropriate value for use in our system. 
 
MATERIALS AND METHODS 
Determination of Necessary Viscosity 
 Based on the parameters set forth by the configuration of the original system, 
several assumptions were established when deriving an equation to calculate the wall 
shear stress seen at the inner wall of the BVM construct.  For purposes of this work, 
luminal flow was assumed to be fully developed, pressure driven, steady and laminar.  
This does not take into account the presence of pulsation and how it can alter shear 
stresses in a tube, a factor that is beyond the scope of this thesis.  In addition to the 
assumed flow characteristics, it was assumed that the construct scaffold is a perfectly 
circular tube.  It was realized that the scaffold is made of a pliable material and may not 
maintain a perfectly circular profile, but for the purposes of these calculations this 
assumption was maintained.  With these assumptions accepted, the following equation 
was established. 
 78 
 
τwall = 32µQ/πD3 
Where: τwall is the calculated wall shear stress (N/m2 or Pascal), µ is the viscosity of the 
perfusion fluid (N•s/m2), Q is the volumetric flow rate (m3/s), and D is the tubing 
diameter of the construct graft (m).  This equation was used to calculate the minimum 
viscosity needed to achieve the desired minimum shear stress of 6 dyne/cm2 or 0.6 
Pascals.  Additionally, it was used to determine the shear stress resulting from flowing 
media with different concentrations of dextran through the BVM construct. 
 
Media Formulation 
 Methylcellulose 
 Based on the literature provided by Sigma-Aldrich, methylcellulose (MC, Sigma-
Aldrich p/n M0555) had the potential to achieve the necessary viscosity in very low 
concentrations, as it is a rather large polymer.  In order to prepare the growth media with 
added MC, the manufacturer’s preparation protocol was followed.  This procedure 
indicated that solubilization should be carried out using water as the solvent.  However, 
for our purposes, it was necessary to use complete growth media in the place of water to 
maintain the proper concentrations of the other components.  For initial tests 2, 4, 6, and 
8% (g/ml) solutions were prepared.  About one-third of the needed volume of media was 
agitated and heated to 80°C.  Once at temperature, the powdered methylcellulose was 
added and allowed to stir until thoroughly dispersed.  To completely solubilize the 
solution, cold media was added to bring the solution to final volume.  The solution was 
cooled while agitating for ~45 minutes.  The solution was then filter sterilized. 
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Dextran 
 Powdered Dextran from Leuconostoc mesenteroides was obtained from Sigma-
Aldrich (Sigma-Aldrich p/n D4751).  Based on previous experience with this polymer, it 
was known that the powder form could be added directly to the complete media, and with 
gentle heating and agitation, solubilization would occur.  As with methylcellulose, 2, 4, 6, 
and 8% (g/ml) solutions of dextran were prepared for initial tests.  Follow up tests 
included concentrations up to 30% dextran in complete growth media.  The appropriate 
amount of powdered dextran was added to the corresponding volume of complete growth 
media in 50ml conical tubes at room temperature.  The tubes were then placed in a 37°C 
water bath for ~5 minutes, and then agitated using a vortex until the powder was 
completely dissolved.  For higher concentrations, additional heated time was required.  
These solutions were then filter sterilized.  A higher MW dextran from Sigma Aldrich 
(P/N D4876) was later tested in the same manner to determine if desired viscosities could 
be achieved at lower polymer concentrations. 
 
Viscosity Testing 
 Dextran 
 The viscosity of the growth media was determined using a Vilastic-3 viscometer 
available from Vilastic Scientific Inc.  This device is designed specifically for use with 
biologic fluids and determines viscosity and elasticity based on the rate at which the fluid 
oscillates in a cylindrical tube.  The Vilastic-3 comes calibrated from the manufacturer 
but if necessary, calibration is performed using water as a baseline fluid.  Based on its 
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makeup and lack of any insoluble suspensions, it was assumed that the growth media was 
a Newtonian fluid. 
Operation of the Vilastic-3 was very straightforward.  Software test parameters 
were set based on manufacturer suggestions for Newtonian fluids in the desired viscosity 
range.  These parameters included: oscillation frequency, integration time, low and high 
drive which were set to 2 Hz, 5 seconds, 10 and 30 respectively.  The low and high drive 
levels are unit less parameters that affect the amplification of the shear and strain rates 
exhibited by the unit during measurement.  With parameters set, the fluid to be tested was 
drawn into the sample chamber at room temperature using a standard syringe.  Once the 
sample was in position, the chamber was sealed and the test run was then initiated 
through the software interface (see Figure 3.1).  The Vilastic software output the shear 
rate, shear strain and the shear stress seen in the sample tube as well as the viscosity and 
elasticity of the fluid. 
 
Figure 3.1 Vilastic-3 Viscometer system. 
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The standard growth media containing 0% dextran was tested to determine the 
shear stress of the original setup.  Subsequent samples were tested to determine what 
concentration of dextran would be required to establish the desired shear stress in our 
system.  These viscosities were then used to calculate the shear stresses that would be 
experienced by the BVM constructs. 
 
Static Culture Test 
 Solutions of growth media containing 0, 10, 14, 20 and 30% dextran were used to 
grow HUVECs in static culture well plates to determine if the added dextran would alter 
the growth of the cells.  HUVECs were grown to confluence in a 75ml T-flask at which 
point they were used to inoculate a set of 6-well plates.  After adding 5 ml of endothelial 
cell media (ECM) with endothelial growth supplement from Science Cell to each well, 1 
ml containing ~5 x 105 cells was used to inoculate each well.  After ~24 hours to allow 
the cells to become adhered to the well surface, the EC media was replaced with 
complete bioreactor media with the dextran concentrations mentioned above.  Each 
concentration was grown in duplicate for a total of 10 wells.  The cultures were 
monitored daily for five days to assess any changes in viable cell density, morphology 
and overall culture health.  Light microscopy was used to visualize and photograph the 
cultures in order to compare the effects of the increased dextran concentrations with those 
grown sans dextran.  For purposes of this study, culture evaluation was done on a 
qualitative basis with confluence estimated based on approximated surface coverage. 
 
Cell Adhesion Tests 
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 The final step of this work involved cultivating the BVM constructs using the 
higher viscosity media to determine if cell adhesion could be maintained under the 
increased shear conditions.  For initial tests, Human Umbilical Vein Endothelial Cells 
(HUVECs) were sodded onto an ePTFE scaffold per the Sodding Protocol (Appendix B).  
These constructs were allowed to grow under steady flow and low shear conditions for 3 
days to allow the cells to become attached to the scaffold under previously established 
conditions. 
To avoid cell loss that may occur from a sudden increase in shear, the 
introduction of increased shear was done in a stepwise, ramp-up manner.  After 3 days of 
growth using media containing no dextran, the low shear bioreactor media on the variable 
groups was replaced with complete bioreactor media containing 8% dextran.  The control 
group received a new batch of bioreactor media with 0% dextran.  For the initial change 
to viscous media (8% dextran), the flow rate was reduced to 10ml/min to produce a wall 
shear stress of ~1.15 dyn/cm2 to allow the cells to adapt to the increase in shear levels.  
After 24 hours of growth under these conditions, the 8% media was replaced with a 14% 
dextran solution and the flow rate was again reduced to 10ml/min to avoid shocking the 
cells with a sudden increase in shear.  The 14% dextran concentration was chosen as it 
will produce the desired minimum shear stress of ~6.4 dyn/cm2.  To achieve this, the flow 
rate was increased to ~28ml/min.  The flow rate was increased in hourly increments of 
~1.5ml/min under steady flow conditions to 19ml/min where it was held over night.  The 
flow rate was increased in the same manner the next morning to 28ml/min. 
For comparative purposes, constructs were maintained in two groups that were 
run at different flow rates (Table 3.1).  Group A experienced lower shear conditions 
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while Group B contained constructs that were exposed to shear forces intended to induce 
cell alignment (≥ 6 dyn/cm2).  
Table 3.1 Shear stress cell adhesion test condition summary. 
 
After 24 hours of growth under these conditions, all setups in Group A were taken down 
and the grafts were placed in Histochoice for later analysis using the same procedure 
described in the cell adhesion test section of Chapter 2.  The control construct (SB1) and 
one exposed to 14% dextran (SB2) in Group B were taken down after 8 hours of flow at 
28ml/min.  The remaining construct in Group B (SB3) was taken down after 24 hours of 
exposure to 28ml/min.  These samples were later analyzed using SEM and BBI staining. 
 
RESULTS 
Estimating Required Viscosity 
 Based on the flow rate of 15 ml/min, the needed viscosity to achieve the desired 
minimum shear stress of 6 dyn/cm2 was approximately 15.2 centipoise or 0.0152 Pa-s.  
This would produce a shear stress of ~6.04 dyn/cm2 in the BVM with a 4mm graft.  If a 
3mm graft was used, the shear stress would be ~14.3 dyn/cm2. 
 
Viscosity Testing on Vilastic-3 Viscometer 
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 Methylcellulose 
 Due to the fact that the preparation procedure for methylcellulose was quite 
rigorous with regard to the temperature required to solubilize the polymer, it was thought 
that certain components of the media such as proteins may be damaged, making it a less 
desirable option.  Filtration of the prepared solutions was problematic as well, with 
higher concentrations taking up to 45 minutes for filtration of ~40ml.  Additionally, some 
unidentified particulates remained on the filter membrane after all of the solution had 
passed through the filter.  Due to these difficulties, methylcellulose was abandoned as a 
potential additive in our system. 
 Dextran 
 In contrast to methylcellulose, media containing dextran proved to be especially 
simple to prepare.  The only difficulty was with solutions of higher concentrations, which 
required additional heating and agitation times.  Filtration time was longer than standard 
media due to the added viscosity, but did not exceed 10 minutes.  Resulting viscosities, 
along with luminal shear stress in a 4mm graft, are shown below in Table 3.2-Table 3.4, 
Figure 3.2 and Figure 3.3.  The figures highlighted in green in Tables 3.2-3.4 indicate 
conditions that create the minimum shear stress of 6 dyn/cm2.  The viscosities and 
resulting shears stresses for concentrations below 10% and flow rates below 16ml/min 
were omitted from the data chart, as they did not produce the minimum shear stress 
required for use in this system.  This finding prompted the decision to increase the flow 
rate. 
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Table 3.2 Calculated shear stress in BVM with 4mm graft at 16-24 ml/min. 
 
Table 3.3 Calculated shear stress in BVM with 4mm graft at 25-33 ml/min. 
 
Table 3.4 Calculated shear stress in BVM with 4mm graft at 34-40 ml/min. 
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Figure 3.2 Viscosity and shear stress of increasing Dextran concentrations at 
different flow rates. 
 
Figure 3.3 Shear stress with increasing flow rates of growth media with varied 
concentrations of Dextran. 
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Characterization of Media Viscosity 
 As mentioned previously, it was assumed that complete growth media with and 
without added dextran was a Newtonian fluid and would not exhibit a change in viscosity 
with changing shear rates.  However, to be certain that this was the case, the solutions 
were tested at different shear rates and were found, in fact, to have the properties of a 
Newtonian fluid (Figure 3.4).   
 
Figure 3.4 Viscosity of different Dextran concentration at varying shear rates to 
show Newtonian property of media.  This data was extrapolated from the results of 
viscosity testing of each dextran concentration. 
Establishing Desired Wall Shear Stress 
As mentioned previously, one of the main objectives of this thesis work was to 
implement the desired conditions with as little disruption to the original system as 
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possible.  However, upon determining the viscosity of the various concentrations of 
dextran, it was realized that in order to achieve the desired minimum shear stress in the 
system of 6 dyn/cm2 with the current flow rate of 15 ml/min, the media would have to be 
over 30% dextran (Sigma p/n 4751).  It was decided that this concentration was too high, 
as it may adversely affect cellular growth.  Thus, a higher molecular weight dextran 
(Sigma p/n D4876) was investigated with the idea that it could provide the desired 
viscosity at lower concentrations.  However, it was found that the higher molecular 
weight dextran (D4876) actually produced a slightly lower viscosity at comparable 
concentration and thus was abandoned as an option (Table 3.5). 
Table 3.5 Viscosity of lower and higher molecular weight dextran in complete 
growth media. 
 
 In order to achieve the minimum shear stress of 6 dyn/cm2, it was decided that the 
flow rate would have to be increased to avoid the need for excessively high dextran 
concentrations.  In an effort to balance the need to use the lowest possible dextran 
concentration and flow rate that would provide desired shear stresses, it was decided that 
the system would be run at 27-28 ml/min with media consisting of 14% dextran (g/ml). 
 
Static Culture Tests 
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 After one day of growth in media containing endothelial cell growth supplement, 
the cells had become well adhered to the bottom surface of the wells with ~95-100% 
confluence (Table 3.6 and Figure 3.5).  After 24 hours (Day1) of growth in the bioreactor 
media with and without dextran, cultures grown in the solution containing 0, 10 and 14% 
dextran all showed similar growth with an observed adhesion and extension of the cell 
bodies and their lamellipodae (Figure 3.6).  The cultures grown in 20% dextran showed 
acceptable adhesion, however, the morphology showed a moderate level of lamellipodae 
retraction resulting in a more spherical appearance (Figure 3.6).   
Table 3.6 Estimated confluence of static cultures of HUVECs grown in bioreactor 
media amended with varied amounts of dextran. 
 
The decrease in confluence relative to increasing dextran concentration as seen in Table 
3.6, may have been due to cytotoxicity of higher dextran levels or a decrease in the gas 
permeability of the higher viscosity medias that contained higher dextran concentrations.  
The decrease in confluence relative to culture time (Days) was most likely due to nutrient 
depletion of the static media.  This trend was consistent in cultures grown in 30% dextran 
with an even more extensive degree of lamellipodae retraction and spherical cell 
morphology (Figure 3.6).  The following days showed a similar progression with cultures 
grown in 0, 10 and 14% maintaining similar adhesion and cell extension.  After 48 hours 
(Day 2) of growth, cultures containing 10 and 14% dextran did show some cell loss, but 
not to any significant degree.  However, the cultures grown in 20 and 30% dextran for 
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two days began to exhibit extensive retraction and increased release from the well 
surface.  After 72 hours (Day 3), the 0, 10 and 14% cultures maintained comparable cell 
adhesion and morphology with a slight increase in cell loss.  At this point, those grown in 
20 and 30% continued to degrade at a more rapid rate.  Particularly, the cultures 
containing 30% dextran contained clumps of dead or released cells.  This overall trend 
continued through Day 5 of culture growth with near complete culture loss in the wells 
containing 30% dextran. 
 
Figure 3.5 HUVECs static culture -Day 0.
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Figure 3.6 Cell morphology and culture appearance of static cultures of HUVECs grown in bioreactor media amended with 
varied amounts of dextran.  Arrows indicate an elapsed time of 48 hours.
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 From the results of this static culture growth test, it is concluded that the use of 
dextran is not toxic to HUVECs as the culture maintained growth in media containing 
dextran for 5 days.  Additionally, when used in concentrations up to 14%, dextran does 
not affect the morphology and overall culture health to any significant degree.  However, 
when used in static cultures at higher concentrations, there was an observed significant 
degree of cell loss, change in morphology and decrease in overall culture health.  This is 
not to say that these concentrations are unsafe for culture use, however before they are 
implemented, further studies should be performed to investigate these effects in perfusion 
systems where growth conditions are more dynamic.  Although it was not determined, the 
greater degree of cell loss in cultures containing higher concentrations of dextran (20 and 
30%) may be due to a decrease in gas exchange and nutrient transfer caused by the 
increased viscosity of these solutions. 
 
Cell Adhesion Tests 
 The setup of the six BVM constructs proceeded without any major difficulties.  
As in the cell adhesion test in Chapter 2, each graft was sodded with approximately 7 x 
106 cells resulting in a sodding density of ~1.6 x 106 per cm2.  When placing the grafts 
into the chambers, extra care was taken to avoid installing any of them under tension as 
was experienced in the pulsatile flow cell adhesion trials. 
The initial 3-day growth period following sodding was carried out under steady 
flow conditions at 15ml/min using standard media containing no dextran.  The only 
complications found during this growth period were minor leaks in the pump tubing of 
constructs SA2 and SB2.  The leaks were sealed and the tubing was moved on the pump 
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head to avoid further cracking.  After 72 hours of growth under these conditions, the 
media was changed to establish the test conditions outlined in Table 3.1.  Each bioreactor 
system was then taken down at the appropriate time points without any adverse 
observations.  Analysis with BBI staining and SEM indicated that the cells remained on 
all of the grafts following exposure to all levels of wall shear stress. 
Analysis of the control construct, SA1, provided more expected results than the 
control construct in the Chapter 2 trials.  BBI imaging indicated the presence of many 
nuclei that appeared to be on and in between the nodes of the ePTFE scaffold.  SEM 
analysis confirmed this, as there was nearly complete filling of the internodal spaces and 
considerable coverage of the nodes themselves.  There was also a considerable degree of 
cell spreading and/or matrix deposition as seen in the SEM image of Figure 3.7.  The 
morphology was different than was expected as there was not a solid monolayer of cells, 
but as mentioned in Chapter 2, this may be in part due to the growth characteristics of 
HUVECs. 
 
Figure 3.7 BBI(A) and SEM(B) imaging of construct SA1 (0% Dextran, 15ml/min 
0.3592 dyn/cm2 for 24 hours). 
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 Imaging of the constructs exposed to mid levels of wall shear stress (~3.43 
dyn/cm2) showed that the cells remained on the graft.  As seen in Figure 3.8, the nuclei 
present on construct SA2 appeared to be somewhat larger than those in construct SA1.  
However visualization with SEM revealed that the surface cell density was not as 
extensive as the control indicating some cell loss caused by exposure to these shear stress 
levels.  The cells present also showed an increased degree of clumping.  The results of 
construct SA3 are not shown, as it was cultivated under identical conditions as SA2 and it 
was similar in appearance (Figure A.13 and Figure A.14).  
 
Figure 3.8 BBI(A) and SEM(B) imaging of construct SA2 (14% Dextran, 15ml/min, 
3.4251 dyn/cm2 for 24 hours). 
 The SB1 construct was cultivated under an increased flow rate, but without any 
Dextran added to the media.  The wall shear stress experienced by the cells in this graft 
was ~0.671 dyn/cm2 for eight hours.  The BBI image of this construct showed a similar 
number of cell nuclei present and although surface cell coverage was slightly more sparse 
than the lower flow control (SA1), it was higher than that of construct SA2.  Note that the 
SEM image of SB1 in Figure 3.9 is taken at a higher magnification. 
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Figure 3.9 BBI(A) and SEM(B) imaging of construct SB1 (0% Dextran, 28ml/min, 
0.6709 dyn/cm2 for 8 hours). 
Construct SB2 was exposed to ~6.4 dyn/cm2 for 8 hours.  Analysis of this 
construct confirmed the retention of the cells on the surface (Figure 3.10).  There were 
many nuclei present on the nodes of the scaffold as shown in the BBI image.  SEM 
imaging showed a moderate degree of filling of the internodal spaces and little cell 
extension and/or matrix deposition. 
 
Figure 3.10 BBI(A) and SEM(B) imaging of construct SB2 (14% Dextran, 28ml/min 
6.3982 dyn/cm2 for 8 hours). 
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 Construct SB3 was exposed to the most rigorous conditions as it experienced ~6.4 
dyn/cm2 for 24 hours.  Analysis revealed that the cells were retained on the scaffold and 
although the BBI image indicates a similar number of nuclei as the SB1 construct, the 
surface density and morphology were somewhat different.  The cells on this scaffold 
appeared slightly more spread out and there was an apparent increase in the degree of cell 
extension and/or matrix deposition as indicated by the fibers along and across the 
scaffold node (Figure 3.11).  For more cell surface images See Appendix A. 
 
Figure 3.11 BBI(A) and SEM(B) imaging of construct SB3 (14% Dextran, 28ml/min, 
6.3982 dyn/cm2 for 24 hours). 
DISCUSSION 
 As with the implementation of pulsatile flow in the BVM bioreactor system, the 
main goal of the work presented in this chapter was to create wall shear stress at the inner 
surface of the graft with the intention of creating an environment in which the phenotype 
and orientation of the sodded cells would be improved over the previously configured 
system.  Consistent with the overall intent of this system as a high throughput, in vitro 
coronary stent testing device, the creation of wall shear stress was approached with ease 
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of use and scalability in mind.  As shear stress had not yet been implemented in this 
system, the primary goals of this part of this thesis were to devise a simple method for 
doing so and to subsequently determine whether or not the applied conditions were 
conducive to cultivation of a cell-lined BVM. 
 The original configuration of the BVM system was not developed with 
appropriate wall shear stress in mind and after testing the viscosity of the media, it was 
found that the shear stress experienced by cells grown in the original system was ~0.35 
dyn/cm2, a figure well below the desired minimum of 6 dyn/cm2.  The immediate thought 
when conceiving a method for increasing this figure was to simply increase the viscosity 
of the media to a level that would invoke desired shear stresses while keeping in mind the 
importance of not affecting cellular growth with said additive.  It was also realized that 
the flow rate may need to be adjusted to achieve the desired shear stress, however this 
was to be used secondary to increasing the viscosity as it would further change the 
original configuration of the system. 
 
Development of Wall Shear Stress 
 Contrary to the development process and preliminary testing involved in the 
pulsatile flow section of this thesis, the physical implementation of wall shear stress into 
the system was less demanding, as it required a simple change in the media used.  The 
original concept was to adulterate the perfusion media to increase the viscosity and 
therefore the resulting shear stress placed on the inner walls of the BVM scaffold.  
Although there were many initial ideas for potential additives that could achieve this, 
background research prompted the decision to investigate methylcellulose and dextran for 
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use in our system.  However, due to the inconvenience of using methylcellulose in our 
media, it was abandoned as an option and testing was carried out using dextran only. 
 After determining the viscosities of various concentrations of dextran, the 
resulting shear stresses at different flow rates in the 4mm diameter graft were calculated.  
As these measurements and calculations were rather straightforward, the difficulty posed 
by this portion of the thesis pertained primarily to deciding what combination of media 
viscosity and flow rate would provide the needed shear stress without bringing harm to 
the cells. 
 
Effect of Dextran on HUVEC Cultures 
Various concentrations of dextran in the bioreactor media were tested in static 
cultures of HUVECs to determine if and at what concentration the culture would be 
hindered simply by the presence of the dextran itself.  Before carrying out this test, shear 
stresses were calculated at various dextran concentrations and flow rates.  Using this data, 
the desired concentration of 14% dextran was selected as it was thought that it would not 
be too high for the wellbeing of the cells and it would provide the desired shear stress 
without requiring an excessively high flow rate.  This was supported by the results of the 
static culture test as cultures grown in up to 14% dextran did not show significantly 
greater cell loss than those grown in lower concentrations.  Although, the cultures grown 
in 20 and 30% dextran did show significant cell loss compared to those grown in 14%, it 
is unknown how the cells would respond to media consisting of dextran concentrations in 
the 15-19% range.  The effects of these additional formulations would require further 
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investigation, which may have been warranted if lower flow rates and/or higher shear 
stress are desired. 
 
Scalability 
 As developed here, the method for implementing appropriate wall shear stress in 
the BVM system did not alter the overall physical configuration of the system to any 
degree.  The bioreactor, tubing, scaffold, and peristaltic pumps were configured exactly 
as presented in the original design.  The only changes were to the media formulation and 
the pump speed required during cultivation.  Based on this statement, the physical 
scalability of this system with desired shear stress is exactly as it was with the original 
system.  However, based on observations during the growth tests performed here, there 
may be a concern during long-term trials.  Due to the increased pump speed required to 
achieve the necessary 28ml/min there may be an issue with reliability of the pump tubing 
as cracks developed at the pump interface that resulted in minor leaks.  This was not 
problematic in the relatively short trials presented here, however, a longer growth period 
may result in excessive media loss and/or culture contamination.  This issue may be 
addressed with the implementation of more robust tubing. 
 
Comparison to Previous Work 
 Due to its importance, the effects of shear stress on the growth and orientation of 
endothelial cells has been extensively investigated [18,37,42,45,48,74,76,86].  Several 
groups have succeeded in developing perfusion bioreactor systems used to cultivate 
TEVGs that apply appropriate shear levels using methods similar to those seen here 
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[25,28,37].  Therefore, the achievement regarding the implementation of shear stress 
presented in this thesis is not unique when compared to the work of other groups in the 
field, but rather a means of confirming its validity in our system.  The results presented 
here are valuable as the goal was not to develop novel methodology, but rather to 
implement shear stress conditions for the proper development of a native-like endothelial 
layer in the BVM.  The novel aspect of this work is in the information provided regarding 
the variety of dextran concentrations and the respective viscosities and corresponding 
shear stresses at different flow rates, as this was not found to be available in previously 
published data.  With this said, the work presented in this thesis should be evaluated as a 
novel condition specific to this BVM system and as groundwork for future development 
of an ideal BVM system. 
 
Cell Adhesion 
 After determining the necessary parameters for achieving specific shear stress 
levels at the graft surface, the final phase of this portion of this thesis was to determine 
whether or not a HUVEC-sodded BVM could maintain cell adhesion with an increase in 
shear forces.  Although the number of grafts cultivated in this investigation does not 
allow for claims that can be considered statistically significant regarding the best 
configuration, it has been demonstrated that shear stresses previously shown to improve 
EC growth can be implemented into this BVM system while maintaining cell adhesion.  
As mentioned above, although establishing shear stress in a bioreactor system such as this 
is not a novel achievement, some degree of accomplishment can be credited to the cells 
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remaining on the scaffold under increased shear on an ePTFE scaffold, as this material is 
not highly conducive to cell adhesion. 
 
Construct Appearance and Cell Morphology 
 As shown in Figure 3.7-Figure 3.11, the analysis of the constructs indicated that 
cells remained on the graft following exposure to all of the various shear stress conditions 
applied in this work.  This was confirmed with the presence of nuclei as well as 
visualization under SEM.  Although simply maintaining cell adhesion was the primary 
goal and measure of success in these trials, more critical examination showed that the 
cells exhibited an undesirable morphology and subsequently did not form a confluent 
monolayer on the graft surface.  For an example of the desired surface appearance of a 
BVM cultivated in this system, see the micrograph of the HMVECs sodded construct 
cultivated in a previous study (Figure 3.12). 
 
Figure 3.12 BBI(A) and SEM(B) images of ePTFE graft sodded with HMVECs (0% 
Dextran, 15ml/min 0.3592 dyn/cm2).  K. Cardinal, unpublished data. 
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As discussed in Chapter 2, the surface morphology seen in constructs cultivated 
for this thesis may have been due to the inherent nature of HUVECs and therefore not a 
direct result of the applied shear conditions.  This possibility is backed by the fact that the 
cell morphology found on the control construct (SA1), which did not experience shear 
stress of any kind, was similar in appearance to those exposed to increased shear.  When 
compared to the micrograph of HMVECs, which was exposed to identical conditions as 
SA1, the resulting appearance of all constructs cultivated in this trial can be considered 
dissimilar.  Therefore, the fact that the control construct in this trial was similar in 
appearance to the variable groups, but dissimilar to the expected results seen in Figure 
3.12, it cannot be concluded that the undesired morphology are a direct result of the 
changes made in this work. 
Although the claim that the unfavorable morphology may be due to the HUVEC 
cell type cannot be backed by the results presented here, the results of several other 
groups’ studies into the behavior of the HUVEC cell type may provide some explanation 
and/or ideas for potential improvements to the protocol used to cultivate HUVEC sodded 
BVM constructs with and without shear [32,47,51].  Further investigation is required to 
determine whether or not the method of implementing shear stress developed in this 
thesis can be used to cultivate a BVM with desirable morphology and surface confluence. 
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CHAPTER 4: DISCUSSION AND CONCLUSIONS 
 
OVERVIEW 
 The primary goal of this thesis was to develop, implement and test the feasibility 
of establishing physiologic flow conditions in a bioreactor system used to cultivate Blood 
Vessel Mimics (BVMs) in an effort to contribute to the overall goal of creating an ideal 
BVM construct.  For purposes of this system, the development of an “ideal” setup would 
maintain its simple, high-throughput configuration, while making changes to the original 
design that will produce a construct with native-like qualities.  The work presented here 
proposes methods for introducing both pulsatile flow and levels of shear stress that are 
intended to improve the phenotypic expression and therefore scientific value of the BVM 
system.  Two key changes other than those presented in this thesis involve replacing the 
ePTFE scaffold with one that exhibits more native-like compliance and improved cell 
adhesion properties along with developing a method for sodding the graft with cell types 
that will create a construct with native-like layering.  These two alterations are currently 
under development and although they are not discussed extensively in this thesis, they are 
necessary to fully realize the benefit of the work presented herein. 
 As discussed previously, the introduction of physiologic pulsatile flow and 
increased wall shear stress will improve the development of sodded cells in the BVM 
bioreactor system.  The pressure fluctuations resulting from pulsatile flow create radial 
hoop stresses and an ensuing strain intended to improve the cell orientation and layer 
composition of the BVM construct.  Although this has been shown to improve the growth 
of ECs, the benefit of this feature has been primarily noticed in the tunica media, or layer 
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containing smooth muscles cells [28,34,57].  Appropriate levels of wall shear stress, on 
the other hand will primarily benefit the development of the EC layer as it has been 
shown to induce proper cell alignment as well as phenotypic and growth factor 
expression [37,45,48]. The work presented here aimed to show that these conditions 
could be introduced in a previously established system in a way that would allow for cell 
adhesion, while maintaining the system’s original simplicity. 
 Although the results of the cell adhesion tests were suboptimal with regard to cell 
morphology in both the pulsatile flow and shear stress trials, the principle goal of 
maintaining some degree of cell adhesion was a success.  Secondary to maintaining 
adhesion, cell morphology and graft surface structure showed a need for improvement.  
The studies in this thesis were intended to establish groundwork for future development 
and experimentation, and in this respect, are viewed as a success.  Based on the 
experiences and results from this work, several aspects of the system were identified as 
potential targets for future studies that can optimize the results of BVM constructs 
cultivated in this system. 
 
FUTURE WORK 
Pulsatile Flow 
 The work performed in this thesis regarding the development of pulsatile flow 
was successful in that a simple, minimally-modified variation of the original system was 
used to cultivate an endothelial cell-sodded BVM construct while maintaining some 
degree of cell adhesion.  However, the resulting system and the construct it was used to 
produce showed some need for improvements. 
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 As mentioned previously, the tunability of the pulsatile pressure conditions could 
be improved.  This can be addressed with three objectives in mind: (1) providing a more 
precisely indexed and adjustable pressurization method that will allow for minute, 
gradual adjustments to the system pressure independent of flow rate, (2) establishing a 
consistent baseline pressure that simulates a native diastolic pressure level, and (3) 
optimization of the pressure ramp-up protocol. 
To improve the tunability of the system pressure, the method for applying 
backpressure could be enhanced.  Possible solutions could involve the incorporation of a 
flow controller design for this application or the placement of check valves inline with 
the system to reduce the tendency for back flow inherent to peristalsis. 
The establishment of a simulated diastolic or baseline pressure has many potential 
solutions that may bring about many potential complications.  The complexity seen in the 
bioreactor systems of other groups cultivating TEVGs is often due to the need to maintain 
this baseline pressure as the system must be very well sealed to prevent leaks and very 
well controlled.  It is unknown how well the current system can maintain elevated 
pressures while still enduring the pressure spikes seen with pulsation.  Because this 
change would add substantial complexity to a system meant to maintain simplicity, the 
need to do so should be investigated by determining whether or not adequate construct 
growth can be achieved by relying solely on the pulsed pressure without the application 
of the baseline pressure. 
The protocol used to ramp up pressure was developed in an effort to gradually 
apply the desired pressure levels without disturbing the cells’ growth or adhesion.  This 
was established without any prior experience with methods that would provide the best 
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possible results.  Future studies could be developed to optimize the timing and rate of this 
increase. 
 Along with improving the qualities of pulsatile flow and the methods for creating 
it, there is potential for investigation into the use of pulsation in the cultivation of a SMC 
sodded construct.  All cell adhesion tests performed in this thesis were carried out using 
endothelial cells and although pulsatile flow has been shown to benefit the phenotypic 
expression of ECs, it has also been shown to be a key aspect in the development of the 
SMC layer in particular [10,41,58,62,68,69].  For this to be fully explored, a different 
scaffold material would most likely be necessary.  The current scaffold material, ePTFE, 
does not allow for much compliance and as a result, the degree of cyclic radial strain 
experienced by the cells is limited.  As our laboratory aims to create an ideal BVM for 
intravascular device testing, the inclusion of SMCs and a more compliant scaffold are 
important endeavors that will allow for the full benefit of pulsatile flow to be realized.  
Currently, both of these needs are being addressed, as protocols for cultivating SMC 
sodded constructs and the creation of electrospun scaffolds are under development. 
In addition to future work regarding the improvements upon the system as it is 
currently configured, the pulsatile flow of our system could also potentially be used to 
study the response of endothelial cells to varying degrees of pressure variation.  This was 
briefly discussed in the Methods section of Chapter 2, as different settings were 
established that corresponded with different hypertensive conditions.  These settings were 
not tested in a sodded BVM and the degree of cell adhesion under these conditions is 
unknown, however these settings can be achieved and are a potential target for future 
studies. 
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Wall Shear Stress 
 In accordance with the initial goal of this work, a simple method for specifying 
and implementing appropriate levels of wall shear stress in an endothelial cell-sodded 
BVM was successfully developed, as discussed in Chapter 3 of this thesis.   Furthermore, 
it was shown that these conditions could be used in the cultivation of a vascular construct 
while maintaining cell adhesion.  Although this can be deemed a success for the purposes 
of this thesis, the work presented here reveals that further work is required to refine these 
conditions in the effort to produce an ideal BVM construct. 
 Unlike the apparent need to address the tunability of pulsatile flow, shear stress in 
the system can be easily and accurately adjusted to the desired level by varying the media 
viscosity and corresponding flow rate.  These levels were characterized in this thesis, and 
further refinement of this characterization of flow conditions and resulting calculated 
shear levels is possible by employing more extensive principles of fluid dynamics.  As 
discussed previously, several assumptions were made as to the flow conditions in the 
BVM scaffold that may have inadvertently disregarded certain characteristics that affect 
resulting shear levels.  To address this, future investigations should determine whether 
the flow in the construct is entirely laminar or if there is some turbulence present as this 
has been shown to greatly affect the results of TEVG cultivation [18,76]. 
 In addition to addressing the possible presence and effect of turbulent flow on 
shear stress in the BVM system, there is a need to address the effect of pulsatile flow on 
the degree of shear stress experienced by the cells on the scaffold.  For purposes of the 
shear stress studies performed in this thesis, the effect of pulsatility on wall shear stress 
was disregarded as the flow was considered to be steady and fully developed.  However, 
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due to the fact that the BVM system will eventually include pulsatile flow, its effects 
must be taken into account as pulsatility has been shown to enhance wall shear stress in a 
setup such as the BVM system [55].  To address this, others groups have included the 
Wormersley parameter in their shear stress calculations [25].  Once the effect of pulsatile 
flow on the calculated shear stress in the BVM system is fully understood, it can be easily 
tested by using media with the required viscosity in the 3-roller, pulsatile setup developed 
in chapter two of this thesis.  Use of the 3-roller pump head will also help prevent the 
problems experienced in the shear stress cell adhesion trials, as the lower pump speed and 
wall thickness of the tubing reduce the chances for cracks to form. 
 Along with more accurately characterizing the flow in the BVM system, there is 
also a potential for improvement in the protocols used to implement shear stress.  Items to 
address include: the concentration of dextran and corresponding flow rate used with the 
shear ramp-up protocol. 
To achieve the desired minimum shear stress of 6 dyn/cm2, the perfusion media 
consisted of 14% dextran.  Though this concentration was not found to hinder cellular 
growth to any significant degree, it is higher than concentrations used by other groups 
and the resulting construct did not exemplify the qualities and desired morphology that 
would be expected from exposure to these shear levels (e.g. cell alignment).  This could 
be due to a number of different factors, however future investigations should focus on 
determining an optimal combination of dextran concentration and flow rate for use in the 
BVM bioreactor system. 
In addition to optimizing the methods for adjusting shear stress levels, future 
work should determine the best possible way to implement shear in the BVM system.  
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The protocols employed in the cell adhesion studies of Chapter 3 were intended to 
gradually increase shear stress in an effort to minimize cell loss that may occur with a 
sudden increase.  However, this gradual increase may have actually increased cell loss 
and/or contributed to the observed undesired surface morphology as it has been shown 
that decreased shear levels can cause degradation and cell retraction in the endothelial 
layer of TEVGs and native blood vessels [46,48].  If this were the case, the resulting 
damage to the cell layer may not have been overcome by exposure to the desire minimum 
shear stress of 6 dyn/cm2 for 24 hours.  Conversely, the ramp-up may need to be more 
gradual as the scaffold material, ePTFE, is inherently problematic in cell adhesion. 
 
Cell Culturing 
 Other than improvements upon the system’s flow characteristics and 
pressurization methods, the resulting cell morphology poses a need for possible change.  
As described in Chapters 2 and 3, the culturing characteristics of HUVECs may present a 
target for future investigations. There were three common procedures found that may be 
employed to improve the results of HUVEC cultivation.  Based on studies by Inoguchi et 
al and Hsu et al on the morphology and surface retention of HUVECs, the first method 
that could be adopted involves an additional step following the sodding of cells onto the 
scaffold.  Both the Inoguchi and Hsu found that incubating the sodded grafts in static 
conditions prior to introducing perfusive flow improved cell retention and spreading 
[31,32].  The second addition to the methods used when cultivating HUVECs in the 
BVM involves the growth media.  The growth media used when culturing the cells 
statically in preparation for sodding contained a growth supplement specific to 
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endothelial cells.  This component was removed from the perfusion media used when 
cultivating the cells in the BVM.  For improved morphology, it is suggested that 
HUVECs be cultured in the BVM with media containing ECGS. [20,47].  The final 
possible improvement to the cultivation procedure involves a change to the graft 
preparation.  Inoguchi et al and Feugier et al found success in their respective studies by 
coating the interior surface of the graft with collagen prior to sodding them with cells 
[20,32].  This would provide a protein to which the cells may better adhere.  Although 
these suggested changes to the procedures used in our lab might improve the qualities of 
the resulting constructs, they add an additional element of complexity to a system that is 
intended to be simple and high throughput and thus may be unnecessary. 
 An alternative to improving the results of cultivating HUVECs is to try using an 
endothelial cell from a different source such as HMVECs.  Although there are many 
sources for ECs, our lab has extensive experience and success with HMVECs in 
particular and would thus eliminate the cells’ growth characteristics as a variable during 
the development of pulsatile flow and shear stress in the BVM system.  However, due to 
the fact that microvessels and not large arteries are the source for this cell type, our lab is 
trying to move away from using them in the BVM.  HMVECs are more prone to 
differentiate than ECs from larger vessels and using a cell type such as HUVECs may 
produce a more native-like large artery in the BVM 
 In addition to optimizing the techniques for culturing human vascular cells used in 
the BVM system, there may be a need to explore the use of the same cell types from 
different species.  This may present a valuable precursor to animal studies.  Similarly, 
there may be a need to specify the genetic variability of the cell lines from which 
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constructs are cultivated.  Currently, BVM constructs are sodded with cells from a single 
cell line at a time.  Although these cell lines are collected from a variety of donor sources, 
further specification and tracking of each cell line used could simulate the variability 
found in clinical human trials. 
 
Additional Future Work and Considerations 
 Apart from designing future studies that aim to improve the methods developed in 
this thesis and other work intended to implement physiologic conditions in this BVM 
system to improve the outcome of the cultivated constructs, there are many potential 
subjects for future investigations using the BVM system as a tool.  As discussed 
previously, the intended use for this model is as an in vitro means to investigate the 
cellular response to implanted coronary stents.  However, because of its versatile design 
it can also be used to study other intravascular devices such as catheters used for 
coronary angioplasty as well as vascular response to blood vessel related conditions and 
drugs.  As an example, our lab has used the BVM system to evaluate intravascular optical 
coherence tomography (OCT). These studies could be carried out with little or no 
modifications to the system as it exists now.  A balloon catheter can be easily inserted 
and activated through the same port used to deploy a stent while a drug study might 
involve simply adding the subject pharmaceutical to the media at some point during 
cultivation. 
Potential studies that could be facilitated by the work presented in this thesis 
include the effects and possible treatment options for vascular disease conditions.  For 
example, the pulsatile flow setup could be used to investigate the effects of hypertension 
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by increasing the system pressure to that which is seen in patients with this condition (as 
outlined in Table 2.2).  Similarly, by altering wall shear stress using the methods 
developed here, the system can be used to study the potential for atherosclerotic plaque 
development with the correct cellular constructs in place.  Along with simply studying 
cellular response to conditions such as these, they can be combined with drug or coronary 
stent studies to determine how the vessel will respond to a drug or the presence of a stent.  
Again, these studies cannot be used to replace in vivo studies, but they can be used as 
preliminary data that may enhance the drug or device development process. 
 Although some development is still required to produce an ideal BVM system, 
when that goal is achieved it may prove to be a valuable tool in the drug and device 
industry.  Along with providing a device or drug company with valuable results that may 
improve their development process, a valid test is important as it may be presented to the 
Food and Drug Administration or other governing bodies as preclinical data in 
Investigational Device Exemption (IDE), PreMarket Approval (PMA) or 510K 
applications [28,48].  Data presented in these applications are used to illustrate that the 
drug or device in question is safe and effective, and if a vascular construct with native 
characteristics can be produced using the BVM bioreactor system, there is potential use 
for it in this manner. 
  
CONCLUSION 
 The ultimate goal of creating pulsatile flow and increasing wall shear stress in the 
BVM bioreactor system was successfully achieved.  In accordance with the initial 
intentions of this thesis, this was performed without any major changes to the overall 
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configuration of the system and as mentioned before, the results of this thesis can be used 
as groundwork for many future studies into the creation of an ideal BVM.  Although our 
system is similar to those of several other groups that have developed TEVG bioreactor 
systems capable of producing high quality, native-like constructs, our BVM bioreactor 
system is superior in its simplicity and use as a high-throughput device testing model.  As 
a result, this system has limitless potential for use as an in vitro model and with some 
development it may eventually provide a means of testing that could significantly benefit 
the medical device industry.  
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APPENDIX A: Additional Figures 
 
Figure A.1 BVM bioreactors in incubator setup for wall shear stress cell adhesion 
trial. 
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Figure A.2 BVM bioreactors in incubator setup for pulsatile flow cell adhesion trial. 
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Figure A.3 SEM image of construct PB1 (72 hours of steady flow on 8-roller pump 
@ 15ml/min and 24 hours of steady flow on 3-roller pump). 
 
Figure A.4 High magnification SEM image of HUVEC on construct PB2 (72 hours 
of steady flow on 8-roller pump @ 15ml/min and 24 hours of pulsatile flow on 3-
roller pump at 18.5 ml/min and ~40mmHg). 
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Figure A.5 BBI image of construct PB3 (72 hours of steady flow on 8-roller pump @ 
15ml/min and 24 hours of pulsatile flow on 3-roller pump at 18.5 ml/min and 
~40mmHg). 
 
Figure A.6 SEM image of construct PB3 (72 hours of steady flow on 8-roller pump 
@ 15ml/min and 24 hours of pulsatile flow on 3-roller pump at 18.5 ml/min and 
~40mmHg). 
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Figure A.7 BBI image of construct PB4 (72 hours of steady flow on 8-roller pump @ 
15ml/min and 24 hours of pulsatile flow on 3-roller pump at 18.5 ml/min and 
~80mmHg). 
 
Figure A.8 SEM image of construct PB4 (72 hours of steady flow on 8-roller pump 
@ 15ml/min and 24 hours of pulsatile flow on 3-roller pump at 18.5 ml/min and 
~80mmHg). 
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Figure A.9 Higher magnification SEM image of construct PB4 (72 hours of steady 
flow on 8-roller pump @ 15ml/min and 24 hours of pulsatile flow on 3-roller pump 
at 18.5 ml/min and ~80mmHg). 
 
Figure A.10 Higher magnification SEM image of construct PB5 (72 hours of steady 
flow on 8-roller pump @ 15ml/min and 24 hours of pulsatile flow on 3-roller pump 
at 18.5 ml/min and ~80mmHg). 
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Figure A.11 Higher magnification SEM image of construct SA1 (0% Dextran, 
15ml/min 0.3592 dyn/cm2 for 24 hours). 
 
Figure A.12 Higher magnification SEM image of construct SB2 (14% Dextran, 
28ml/min 6.3982 dyn/cm2 for 24 hours). 
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Figure A.13 BBI image of construct SA3 (14% Dextran, 15ml/min, 3.4251 dyn/cm2 
for 24 hours). 
 
Figure A.14 SEM image of construct SA3 (14% Dextran, 15ml/min, 3.4251 dyn/cm2 
for 24 hours). 
 130 
APPENDIX B: Procedural Protocols 
 
LABCHART PRESSURE ACQUISITION SYSTEM 
Initiating the System 
Turn on the power to the PC, AD Instruments Input Amplifier and Bridge Amp 
Start the LabChart software. 
Open the Input Amplifier window. 
 Select an appropriate Range depending on the current input voltage (10mV) 
 Shift and stretch the vertical amplitude axis to make the best use of the available 
display area 
 Leave all other settings as the default 
Press OK 
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Units Conversion/Calibration 
 
Open the Units Conversion window by selecting the Channel 1 Drop box 
 Ensure that “2-point Calibration” is displayed in the drop box at the top of the 
window. 
 Convert the input voltage signal of channel 1 to “mmHg” using the Unit drop box. 
 For Point 1: enter the current input voltage in the left field and 0 mmHg in the right 
field. 
 Connect the mercury manometer to the Pressure Transducer. 
 Pump the manometer up to 200 mmHg 
 For Point 2: enter the new input voltage in the left field and 200 mmHg in the right 
field 
Press OK 
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Channel Settings 
 
In the Setup Menu select “Channel Settings…” 
Change the Number of Channels to “3” 
Press OK 
Select “Cyclic Variables” in the Channel 2 drop box 
Change the Source to “Channel 1” 
Ensure that “Rate meter” is displayed in the second drop box 
Press OK 
Select “Arithmetic” in the Channel 3 drop box 
Enter “Ch 2/3.25” in the Channel 3= dialog box 
Press OK 
 
 
 
 
Taking Measurements and Recording Pressure 
 
The system is now ready to record system pressure. 
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Start pump, press the Start button in the upper right corner of the window. 
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OPERATION OF THE VILASTIC-3 VISCOMETER 
 
STARTUP 
Turn on Vilastic-3 viscometer and allow it to warm up for at least 30 minutes before 
analyzing samples. 
Turn on PC and Start VMax Software. 
Ensure that the correct sample tube is selected on the home screen. 
 
SAMPLE FILLING 
Obtain an appropriate sample cup. 
The standard sample cups (red) require 1 ml of sample when using the 1 mm i.d. 
measurement tube or up to 1.5 ml of sample with the 2mm i.d. tube. 
The small sample cups (clear) can be used for smaller sample volumes with only the 
1 mm i.d. measurement tube. 
Place the sample cup into the sample cup holder of the measurement tube assembly. 
Using the standard sample cup, fill the cup with ~1 ml of sample. Take care not to inject 
any air bubbles into the sample.  
Thread the sample cup holder onto the bottom of the measurement tube. 
To begin the sample loading procedure, rotate the stopcock lever to the fill position. 
Pull up on the syringe approximately 0.010 ml. 
This will form an air slug in the measurement tube that during the filling procedure 
will sweep the tube clear of residual water. 
Return the stopcock to the discharge position. 
Insert the thermistor into the hole located on the measurement tube. 
Move the stopcock lever to the fill position and slowly draw up on the syringe. 
The sample should move through the tube, pushing the air slug into the clear chamber 
of the tube. 
NOTE If the air bubble does not release from the top of the tube or attaches to the 
walls of the acrylic reservoir, the tube and system should be thoroughly cleaned to 
remove contaminants. 
Continue drawing up with the syringe until this air slug moves above and beyond the 
stopcock. This should leave a water/sample interface in the clear chamber of the tube. 
 This will take approximately 0.25 ml of sample. 
If you are using the red cups and have placed at least 1 ml of sample in the cup 
continue to draw-up on the syringe until 0.4 mls have been drawn. 
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Return the stopcock to the discharge position. The tube is now filled and ready for 
measurement.  
 
CAUTION: PRESSURE SENSOR LIMITS  If the pressure in the measurement 
system exceeds 40 psi, the pressure sensor may be damaged.  Be very careful  during 
the filling and purging operation not to produce excessive pressure that could damage 
the pressure sensor. During measurements the pressure will not exceed ~1 psi; if the 
measurement tube is blocked then it is possible to develop extreme pressures when 
filling the measurement tube that could damage the sensor. 
 
DENSITY For accurate calculations, the density of a test sample should be known to 
within 1% or better accuracy. The sensitivity of measured values to density can be 
determined by modifying the density value a small amount and recalculating the data. 
To enter the density select Set Up menu option and the Density submenu option. 
 
 
SAMPLE EVALUATION  
 
Perform a quick evaluation of the test sample at two operator-selected drive levels to 
determine the possible measurement range of shear rate or strain for a given fluid sample. 
 
When testing 0-30% dextran media, use the following settings. 
 Enter “2” in the Frequency box 
 
 Enter “5” in the Integration Time box 
 
 Enter “10” in the Low Drive box  
 
 Enter “30” in the High Drive box 
 
Press Evaluate Sample 
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After measurements are completed diagnostics will appear on screen. The diagnostics 
indicate if there are any questionable measurements. After the display of diagnostics, the 
measured properties of the fluid at the two drive levels are displayed. The results are used 
by the software to determine the minimum and maximum shear rate or strain possible.  
 
 
SET PROTOCOL  
 
After a sample evaluation has been completed the option to set a sequence of shear rate or 
shear strain measurements is available. 
 
Select Set Protocol under the Protocols menu to set the parameters of the run. 
 
The frequency of measurement is fixed at the frequency of the sample evaluation. 
 
Ensure that the integration time is set to 5 sec. 
 
Select “Shear Rate” in the measurement sweep options 
 The acceptable range of the sweep parameter was determined by the sample 
evaluation.  
Enter a minimum and maximum shear rate within this range. 
If the sample evaluation did not produce the desired range, repeating the sample 
evaluation at other drive levels or Drive Switch position can produce different sweep 
parameter range.  
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Enter the number of measurements desired. 
 
Leave all other setting at the default selection 
 
Press Continue 
 
 
 
 
 
MEASUREMENTS  
 
Once a STRETCH protocol or previous protocol has been established to initiate 
measurements;  
 
Select the menu option Run/Calculate. 
 
 Select Measure and Calculate. 
 
 Click Start RUN 
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The viscosity vs. shear rate plot will be displayed during the measurements. 
 
When all measurements are complete, the resulting data will be displayed and can be 
viewed in text and graphical formats. 
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APPENDIX C: Trial Construct Location 
 
Block #
Sample 
Description
Sample 
Orientation
Date 
Embedded
09-019 SB3 Cross 4/14/09
09-020 SB2 Cross 4/14/09
09-021 SB1 Cross 4/14/09
09-022 SA2 Cross 4/14/09
09-023 SA3 Cross 4/14/09
09-024 SA1 Cross 4/14/09
09-025 PB5 Cross 4/14/09
09-026 PB4 Cross 4/14/09
09-027 PB3 Cross 4/14/09
09-028 PB1 Cross 4/14/09
09-029 PB2 Cross 4/14/09
09-030 PA1 Cross 4/14/09
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APPENDIX D: Figure Reprint Permissions 
 
Usage Agreement – Encyclopedia Britannica 
Terms of Use 
These Terms of Use govern your use of Encyclopædia Britannica® Online 
and, unless other terms and conditions expressly govern, any other 
electronic services provided by Encyclopædia Britannica, Inc. ("Britannica") 
that may be available from time to time (collectively, the "Services"). 
General: Your use of the Services constitutes your agreement to these 
Terms of Use. If you do not agree with these Terms of Use, please do not 
use the Services. Britannica reserves the right to change, modify, add, or 
remove portions of these Terms of Use at any time. Please check this page 
periodically for any modifications. Your use of any of the Services following 
the posting of changes constitutes your acceptance of the changes. 
Ownership: The content on the Services is the property of Britannica, its 
affiliated companies or licensors and is protected by international copyright, 
patent, and trademark laws. 
Advertising:Advertisements, promotions, and marketing messages may appear 
on the Services from time to time. 
Use of Content: You may display, reproduce, print or download content on 
the Services only for your personal, non-commercial use. If you are a 
teacher, scholar or student, you may copy reasonable portions of the 
content for lesson plans, interactive whiteboards, reports, dissertations, 
presentations, school newspapers and for similar nonprofit educational 
purposes to the extent permitted by applicable law. In each case, however, 
you may not remove or alter any copyright, trademark, service mark or other 
proprietary notices or legends. You may not publish, distribute, retransmit, 
sell or provide access to the content on the Services, except as permitted 
under applicable law or as described in these Terms of Use. Britannica works 
to ensure that all the content on its Services is in compliance with 
applicable U.S. copyright laws. However, in the case of works on the 
Services authored by parties other than Britannica, you may wish to check 
on their copyright status before downloading them if you are in another 
country. 
 
If you want to reproduce or use content for any purpose or in any manner 
other than as described above, you will need Britannica's permission. 
Requests should be directed to this syndication form. 
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Permissions Assistant  
Wiley-Blackwell 
9600 Garsington Road 
Oxford OX4 2DQ 
UK 
Tel: +44 (0) 1865 476149 
Fax: +44 (0) 1865 471158 
Email: katie.wade@wiley.com 
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-----Original Message----- 
From: Marc Dawson [mailto:mcdawson78@hotmail.com]  
Sent: 24 April 2009 02:11 
To: Permission Requests - UK 
Subject: Permission request 
 
Hello, 
 
I am a Master student at California Polytechnic State University in San Luis 
Obispo, CA and I would like to use a figure from one of your publications in 
my Masters Thesis. 
 
The Article: 
 
Pulse wave analysis. British journal of clinical pharmacology, 2001. 51(6) 
 
Authored by: 
 
O'Rourke, M.F., A. Pauca, and X.J. Jiang 
 
Figure 1, page 509 
 
My paper will be available to university students and faculty only.  Not 
public. 
 
Thank you, 
 
Marc C. Dawson 
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